

þ		QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
		For the quarterly period ended March 31, ~~2015~~2016



o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

(Exact name of registrant as specified in its charter)




DELAWARE		77-0021975
(State or other jurisdiction of incorporation or		(I.R.S. Employer Identification No.)
organization)

~~5 CONCOURSE PARKWAY, SUITE 3200~~1 EBIX WAY
~~ATLANTA,~~JOHNS CREEK, GEORGIA		~~30328~~30097
(Address of principal executive offices)		(Zip Code)



Large accelerated filer oþ	Accelerated filer þo	Non-accelerated filer o (Do not check if a smaller reporting company)	Smaller reporting company o

PART I — FINANCIAL INFORMATION

Item 1: CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Ebix, Inc. and Subsidiaries

Condensed Consolidated Statements of Income

(In thousands, except per share data)

Ebix, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income

~~Table of Contents~~

Ebix, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(In thousands, except share amounts)


	March 31, 2015		December 31, 2014			March 31, 2016		December 31, 2015
ASSETS	(Unaudited)					(Unaudited)
Current assets:
Cash and cash equivalents	$	27,197	$	52,300		$	69,020	$	57,179
Short-term investments	265		281			2,308		1,538
Trade accounts receivable, less allowances of $1,529 and $1,619, respectively	44,869		41,100
Deferred tax asset, net	2,021		2,113
Trade accounts receivable, less allowances of $1,046 and $3,388, respectively						56,503		47,171
Other current assets	8,643		8,067			11,423		10,942
Total current assets	82,995		103,861			139,254		116,830

Property and equipment, net	28,121		24,661			34,154		34,088
Goodwill	399,408		402,220			403,210		402,259
Intangibles, net	46,875		49,371			50,141		51,848
Indefinite-lived intangibles	30,887		30,887			30,887		30,887
Capitalized software development costs, net						3,226		3,489
Deferred tax asset, net	19,203		18,758			23,892		23,732
Other assets	5,739		4,553			12,636		12,856
Total assets	$	613,228	$	634,311		$	697,400	$	675,989

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities	$	18,471	$	40,121		$	14,687	$	23,043
Accrued payroll and related benefits	4,554		5,280			5,747		4,932
Current portion of long term debt and capital lease obligations, net of discount of $0 and $7, respectively	631		936
Current portion of long term debt and capital lease obligations, net of discount of $0 and $3, respectively						608		606
Current deferred rent	282		268			246		232
Contingent liability for accrued earn-out acquisition consideration	887		887			2,143		1,706
Deferred revenue	22,858		22,192			20,557		20,519
Other current liabilities	102		102			248		228
Total current liabilities	47,785		69,786			44,236		51,266

Revolving line of credit	135,465		120,465			226,465		206,465
Long term debt and capital lease obligations, less current portion, net of discount of $7	593		593
Long term debt and capital lease obligations, less current portion						33		35
Other liabilities	2,449		2,179			3,324		3,332
Contingent liability for accrued earn-out acquisition consideration	4,443		4,480			1,599		2,571
Deferred revenue	1,837		2,496			3,275		1,968
Long term deferred rent	1,962		2,091			1,269		1,381
Total liabilities	194,534		202,090			280,201		267,018

Commitments and Contingencies, Note 5

Stockholders’ equity:
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at March 31, 2015 and December 31, 2014	—		—
Common stock, $0.10 par value, 60,000,000 shares authorized, 35,271,413 issued and outstanding, at March 31, 2015 and 36,232,074 issued and 36,191,565 outstanding at December 31, 2014	3,527		3,619
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at March 31, 2016 and December 31, 2015						—		—
Common stock, $0.10 par value, 60,000,000 shares authorized, 32,977,713 issued and outstanding, at March 31, 2016 and 33,416,110 issued and outstanding at December 31, 2015						3,298		3,342
Additional paid-in capital	113,383		137,101			43,806		57,120
Treasury stock (no shares as of March 31, 2015 and 40,509 shares as of December 31, 2014)	—		(76		)
Treasury stock (no shares as of March 31, 2016 and December 31, 2015)						—		—


Retained earnings	325,333			309,726			398,524			378,787
Accumulated other comprehensive loss	(23,549		)	(18,149		)	(28,621		)	(30,278		)
Total stockholders’ equity	418,694			432,221
Total Ebix, Inc. stockholders’ equity							417,007			408,971
Noncontrolling interest (see Note 8)							192			—
Total stockholder's equity							$	417,199		$	408,971
Total liabilities and stockholders’ equity	$	613,228		$	634,311		$	697,400		$	675,989

~~Table of Contents~~

Ebix, Inc. and Subsidiaries

Condensed Consolidated Statements of Stockholders’ Equity

(unaudited)

(In thousands except for share figures)


	Common Stock																						Common Stock
	Issued Shares		Amount			Treasury Stock Shares		Treasury Stock Amount			Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total			Issued Shares		Amount			Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Noncontrolling interest		Total

Balance, December 31, 2014	36,232,074		$	3,619		(40,509	)	$	(76	)	$	137,101		$	309,726		$	(18,149	)	$	432,221
Net income	—		—			—		—			—			18,336			—			18,336
Balance, December 31, 2015																							33,416,110		$	3,342		$	57,120		$	378,787		$	(30,278	)	$	—	$	408,971
Net income attributable to Ebix, Inc.																							—		—			—			22,159			—			—		22,159
Net income attributable to noncontrolling interest (see Note 8)																																					192		192
Cumulative translation adjustment	—		—			—		—			—			—			(5,400		)	(5,400		)	—		—			—			—			1,657			—		1,657
Repurchase and retirement of common stock	(994,869	)	(100		)						(24,123		)							(24,223		)	(465,560	)	(47		)	(13,921		)							—		(13,968		)
Vesting of restricted stock	55,802		6			—		—			(6		)	—			—			—			15,478		2			(2		)	—			—			—		—
Exercise of stock options	56,250		6			—		—			1,111			—			—			1,117			13,500		1			28			—			—			—		29
Share based compensation	—		—			—		—			458			—			—			458			—		—			647			—			—			—		647
Tax benefit related to share-based compensation	—		—			—		—			31			—			—			31			—		—			—			—			—			—		—
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	(37,335	)	(4		)	—		—			(1,113		)	—			—			(1,117		)	(1,815	)	—			(66		)	—			—			—		(66		)
Retirement of treasury stock	(40,509	)	—			40,509		76			(76		)	—			—			—
Dividends paid	—		—			—		—			—			(2,729		)	—			(2,729		)	—		—			—			(2,422		)	—			—		(2,422		)
Balance, March 31, 2015	35,271,413		$	3,527		—		$	—		$	113,383		$	325,333		$	(23,549	)	$	418,694
Balance, March 31, 2016																							32,977,713		$	3,298		$	43,806		$	398,524		$	(28,621	)	$	192	$	417,199

~~Table of Contents~~

Ebix, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)


	Three Months Ended						Three Months Ended
	March 31,						March 31,
	2015			2014			2016			2015
Cash flows from operating activities:
Net income	$	18,336		$	15,417
Net income attributable to Ebix, Inc.							$	22,159		$	18,336
Net income attributable to noncontrolling interest							192			—
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,597			2,552			2,720			2,597
Provision (benefit) for deferred taxes	(161		)	(441		)
Benefit for deferred taxes							(165		)	(161		)
Share based compensation	458			395			647			458
Provision for doubtful accounts	9			353			(241		)	9
Debt discount amortization on promissory note payable	7			10			—			7
Unrealized foreign exchange (gain)	(672		)	216
(Gain) loss on put option	—			(454		)
Unrealized foreign exchange gain							(48		)	(672		)
Amortization of capitalized software development costs							326			—
Reduction of acquisition earnout accruals	—			(1,762		)	(511		)	—
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable	(4,689		)	(4,716		)	(8,669		)	(4,689		)
Other assets	(1,250		)	576			(220		)	(1,250		)
Accounts payable and accrued expenses	(21,215		)	(65		)	(7,563		)	(21,215		)
Accrued payroll and related benefits	(564		)	1,029			717			(564		)
Deferred revenue	308			(2		)	1,258			308
Deferred rent	(68		)	(163		)	(80		)	(68		)
Reserve for potential uncertain income tax return positions	87			2,133			50			87
Liability - securities litigation settlement payment	(690		)	(4,218		)	—			(690		)
Other liabilities	165			(56		)	(38		)	165
Net cash provided/(used) by operating activities	(7,342		)	10,804
Net cash provided (used) by operating activities							10,534			(7,342		)

Cash flows from investing activities:
Acquisition of Media Health, net of cash acquired	(1,000		)	—
Acquisition of CurePet, Inc., net of cash acquired	—			3
Acquisition of Via Media Health, net of cash acquired							—			(1,000		)
Capitalized software development costs							(144		)	—
Purchases of marketable securities	—			(10		)	(596		)	—
Capital expenditures	(5,778		)	(413		)	(1,028		)	(5,778		)
Net cash used in investing activities	(6,778		)	(420		)	(1,768		)	(6,778		)

Cash flows from financing activities:
Proceeds from / (Repayments) on revolving line of credit, net	15,000			—
Principal payments of term loan obligation	—			(2,406		)
Proceeds from revolving line of credit, net							20,000			15,000
Repurchases of common stock	(22,282		)	(2,234		)	(14,787		)	(22,282		)
Excess tax benefit from share-based compensation	31			(3,200		)	—			31
Proceeds from the exercise of stock options	1,117			788			29			1,117
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	(1,117		)	(25		)	(66		)	(1,117		)
Dividend payments	(2,729		)	(2,896		)	(2,422		)	(2,729		)
Principal payments of debt obligations	(12		)	(9		)	—			(12		)
Payments of capital lease obligations	—			(56		)
Net cash used in financing activities	(9,992		)	(10,038		)
Net cash provided by (used in) financing activities							2,754			(9,992		)
Effect of foreign exchange rates on cash	(991		)	708			321			(991		)
Net change in cash and cash equivalents	(25,103		)	1,054			11,841			(25,103		)
Cash and cash equivalents at the beginning of the period	52,300			56,674			57,179			52,300
Cash and cash equivalents at the end of the period	$	27,197		$	57,728		$	69,020		$	27,197
Supplemental disclosures of cash flow information:
Interest paid	$	2,335		$	208		$	1,987		$	2,335
Income taxes paid	$	20,163		$	3,087		$	7,015		$	20,163

See accompanying notes to the condensed consolidated financial statements.

Supplemental schedule of noncash financing activities:

Effective January 27, 2014 Ebix acquired the entire business of CurePet, Inc. ("CurePet") in an asset purchase agreement with the total purchase consideration being in the amount of $6.35 million of which included a possible future one time contingent earnout payment of up to $5.0 million based on earned revenues over the subsequent thirty-six month period following the date of the acquisition. This contingent earnout liability is estimated to have a fair value of zero. Additional required cash consideration of $1.35 million was offset against open receivable balances due to Ebix, Inc. from CurePet, and thusly no actual cash outlay was

~~made by Ebix, Inc. Previously during 2012, Ebix acquired a minority19.8% interest in CurePet for cash consideration in the amount of $2.0 million.~~

During the three months ended March 31, ~~2015~~2016 there were ~~37,335~~1,815 shares, totaling ~~$1.12 million, forfeited~~$66 thousand, used to satisfy exercise costs and the ~~recipients~~recipients' income tax obligations related to stock options exercised and restricted stock vesting.

As of ~~March~~December 31, 2015 there were ~~64,893~~25,000 shares totaling $820 thousand of share repurchases ~~totaling $1.94 million~~ that were not settled until ~~April 2015.~~January 2016.

Ebix, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

Note 1: Description of Business and Summary of Significant Accounting Policies

Description of Business— Ebix, Inc. and subsidiaries (“Ebix” or the “Company”) is an international supplier of on-demand software and e-commerce solutions to the insurance, ~~industry.~~healthcare and financial industries. Ebix provides various application software products for the insurance industry ranging from data exchanges, carrier systems, and agency systems, to custom software development for business entities across the insurance industry. The Company's products feature fully customizable and scalable on-demand software applications designed to streamline the way insurance professionals manage distribution, marketing, sales, customer service, and accounting activities. The Company has its headquarters in ~~Atlanta,~~Johns Creek, Georgia and also conducts operating activities in Australia, Canada, India, New Zealand, Singapore, United Kingdom and Brazil. International revenue accounted for ~~23.9%~~25.7% and ~~32.3%~~23.9% of the Company’s total revenue for the three months ended March 31, ~~2015~~2016 and ~~2014~~2015, respectively.

The Company’s revenues are derived from four product/service groups. Presented in the table below is the breakout of our revenue streams for each of those product/service groups for the three months ended March 31, ~~2015~~2016 and ~~2014~~2015.

Summary of Significant Accounting Policies

Basis of Presentation—The accompanying unaudited condensed consolidated financial statements and these notes have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and in accordance with U.S. Generally Accepted Accounting Principles ("GAAP") with the effect of inter-company balances and transactions eliminated. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP and SEC rules have been condensed or omitted as permitted by and pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. These unaudited condensed consolidated financial statements contain adjustments (consisting only of normal recurring items) necessary to fairly present the consolidated financial position of the Company and its consolidated results of operations and cash flows. Operating results for the three months ended March 31, ~~2015~~2016 and ~~2014~~2015 are not necessarily indicative of the results that may be expected for future quarters or the full year of ~~2015.~~2016. The condensed consolidated December 31, ~~2014~~2015 balance sheet included in this interim period filing has been derived from the audited financial statements at that date but does not necessarily include all of the information and related notes required by GAAP for complete financial statements. These condensed interim financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2014~~2015.

~~Reclassification—~~The change in reserve for potential uncertain income tax return positions had been previously netted against the provision for deferred taxes line in the consolidated statements of cash flows, it is now shown separately. Also, beginning in 2014 the Company has applied the new provisions under Financial Accounting Standard ("FAS") update No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, A Similar Tax Loss, or a Tax Credit Carryforward Exists and as more fully described in Note 6 "Income Taxes". A portion of potential uncertain income tax return positions previously reported in "Other Liabilities" on the condensed consolidated balance sheets are now netted against the "Deferred tax asset, net" line in the long term asset section of the condensed consolidated balance sheets.

Advertising—With the exception of certain direct-response costs, advertising costs are expensed as incurred. Advertising costs amounted to ~~$496 thousand~~$1.7 million and ~~$121~~$663 thousand in Q1the first three months of 2016 and 2015, ~~and 2014,~~ respectively, and are included in sales and marketing expenses in the accompanying Condensed Consolidated Statements of Income. Sales and marketing expenses have been reduced in ~~Q1 2015~~the first three months of 2016 as a result of the deferment of (net of amortization) ~~$1.2 million~~$86 thousand of certain direct-response advertising costs associated with our ~~recent~~ acquisition of Oakstone, which have been capitalized in accordance with Accounting Standards Codification

("ASC") Topic 340. These costs are being amortized to expense over periods ranging from twelve to twenty-four months based on the type of product the customer purchases.

Fair Value of Financial Instrument—The Company follows the relevant GAAP guidance concerning fair value measurements which provides a consistent framework to define, measure, and disclose the fair value of assets and liabilities in financial statements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction. This guidance establishes a three-level hierarchy priority for disclosure of assets and liabilities recorded at fair value. The ordering of priority reflects the degree to which objective data from external active markets are available to measure fair value. The classification of

assets and liabilities within the hierarchy is based on whether the inputs to the valuation methodology used for measurement are observable or unobservable.

Level 1 Inputs - Unadjusted quoted prices available in active markets for identical investments to the reporting entity at the measurement date

Level 2 Inputs - Other than quoted prices included in Level 1 inputs, that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

Level 3 Inputs - Unobservable inputs, which are used to the extent that observable inputs are not available, and used in situations where there is little or no market activity for the asset or liability and wherein the reporting entity makes estimates and assumptions related to the pricing of the asset or liability including assumptions regarding risk.

A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

As of March 31, ~~2015~~2016 the Company had the following financial instruments to which it had to consider fair values and had to make fair assessments:

Other financial instruments not measured at fair value on the Company's unaudited condensed consolidated balance sheet at March 31, ~~2015~~2016 but which require disclosure of their fair values include: cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, accrued payroll and related benefits, capital lease obligations, and debt under the revolving line of credit with Regions Financial Corporation. The Company believes that the estimated fair value of such instruments at March 31, ~~2015~~2016 and December 31, ~~2014,~~2015, approximates their carrying value as reported on the unaudited Condensed Consolidated Balance Sheet.

Additional information regarding the Company's assets and liabilities that are measured at fair value on a recurring basis is presented in the following tables:

~~Table of Contents~~


	Fair Values at Reporting Date Using*									Fair Values at Reporting Date Using*
Descriptions	Balance, March 31, 2015		Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)			Balance, March 31, 2016		Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(In thousands)									(In thousands)
Assets
Available-for-sale securities:
Commercial bank certificates of deposits	$	265	$	265	$	—	$	—		$	2,308	$	2,308	$	—	$	—
Total assets measured at fair value	$	265	$	265	$	—	$	—		$	2,308	$	2,308	$	—	$	—

Liabilities
Derivatives:
Contingent accrued earn-out acquisition consideration (a)	5,330		—		—		5,330			$	3,742	$	—	$	—	$	3,742
Total liabilities measured at fair value	$	5,330	$	—	$	—	$	5,330		$	3,742	$	—	$	—	$	3,742

(a) The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected cash flows, rate of return, and probability assessments.
* During the three months ended March 31, 2015 there were no transfers between fair value Levels 1, 2 or 3.
* During the three months ended March 31, 2016 there were no transfers between fair value Levels 1, 2 or 3.									* During the three months ended March 31, 2016 there were no transfers between fair value Levels 1, 2 or 3.

~~Table of Contents~~

For the Company's assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the following table provides a reconciliation of the beginning and ending balances for each category therein, and gains or losses recognized during the three months ended March 31, ~~2015~~2016 and during the year ended December 31, ~~2014:~~2015:


Fair Value Measurements Using Significant Unobservable Inputs (Level 3)	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)							Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Contingent Liability for Accrued Earn-out Acquisition Consideration		Balance, March 31, 2015			Balance, December 31, 2014				Balance, March 31, 2016			Balance, December 31, 2015
		(in thousands)							(in thousands)

Beginning balance		$	5,367		$	14,420			$	4,277		$	5,367

Total remeasurement adjustments:
(Gains) or losses included in earnings **		—			(10,237		)		(511		)	(1,533		)
Reductions recorded against goodwill									—			(2,000		)
Foreign currency translation adjustments ***		(37		)	(314		)		(24		)	(73		)

Acquisitions and settlements
Business acquisitions		—			4,312				—			2,516
Settlement payments		—			(2,814		)		—			—

Ending balance		$	5,330		$	5,367			$	3,742		$	4,277

The amount of total (gains) or losses for the period included in earnings or changes to net assets, attributable to changes in unrealized (gains) or losses relating to assets or liabilities still held at period-end.		$	—		$	(8,911	)		$	(511	)	$	(1,533	)

** recorded as an adjustment to reported general and administrative expenses	** recorded as an adjustment to reported general and administrative expenses							** recorded as an adjustment to reported general and administrative expenses
*** recorded as a component of other comprehensive income within stockholders' equity	*** recorded as a component of other comprehensive income within stockholders' equity							*** recorded as a component of other comprehensive income within stockholders' equity

Quantitative Information about Level 3 Fair Value Measurements

The significant unobservable inputs used in the fair value measurement of the Company's contingent consideration liabilities designated as Level 3 are as follows:

~~Table of Contents~~

Sensitivity to Changes in Significant Unobservable Inputs

As presented in the table above, the significant unobservable inputs used in the fair value measurement of contingent consideration related to business acquisitions are projected revenue forecasts as developed by the relevant members of Company's management team and the probability of achievement of those revenue forecasts. The discount rate used in these calculations is 1.75%. Significant increases (decreases) in these unobservable inputs in isolation would result in a significantly higher (lower) fair value measurement. The Company applies these terms in its calculation and determination of the fair value of contingent earn out liabilities for purchased businesses as part of the related valuation and purchase price allocation exercise for the corresponding acquired assets and liabilities. During the 1st quarter of 2016 the cited contingent earn out liabilities were adjusted because of changes to anticipated future revenues from these acquired businesses.

Revenue Recognition—The Company derives its revenues primarily from subscription and transaction fees pertaining to services delivered over our exchanges or from our ASP platforms, fees for risk compliance solution services, and fees for software development projects including associated fees for consulting, implementation, training, and project management provided to customers with installed systems and applications. Sales and value-added taxes are not included in revenues, but rather are recorded as a liability until the taxes assessed are remitted to the respective taxing authorities.

In accordance with Financial Accounting Standard Board (“FASB”) and SEC accounting guidance on revenue recognition, the Company considers revenue earned and realizable when: (a) persuasive evidence of the sales arrangement exists, provided that the arrangement fee is fixed or determinable, (b) delivery or performance has occurred, (c) customer acceptance has been received or is assured, if contractually required, and (d) collectability of the arrangement fee is probable. The Company uses signed contractual agreements as persuasive evidence of a sales arrangement. We apply the provisions of the relevant generally accepted accounting principles related to all transactions involving the license of software where the software deliverables are considered more than inconsequential to the other elements in the arrangement.

For contracts that contain multiple deliverables, we analyze the revenue arrangements in accordance with the relevant technical accounting guidance, which provides criteria governing how to determine whether goods or services that are delivered separately in a bundled sales arrangement should be considered as separate units of accounting for the purpose of revenue recognition. These types of arrangements include deliverables pertaining to software licenses, system set-up, and professional services associated with product customization or modification. Delivery of the various contractual elements typically occurs over periods of less than eighteen months. These arrangements generally do not have refund provisions or have very limited refund terms.

Software development arrangements involving significant customization, modification or production are accounted for in accordance with the appropriate technical accounting guidance issued by FASB using the percentage-of-completion method. The Company recognizes revenue using periodic reported actual hours worked as a percentage of total expected hours required to complete the project arrangement and applies the percentage to the total arrangement fee.

Accounts Receivable and the Allowance for Doubtful Accounts Receivable—Reported accounts receivable include $~~33.8~~42.9 million of trade receivables stated at invoice billed amounts and $13.6 million of unbilled receivables, net of the estimated allowance for doubtful accounts receivable in the amount of $~~1.5~~1.0 million, ~~and~~ ~~$11.1 million~~ ~~of unbilled receivables.~~. The unbilled receivables pertain to certain projects for which the timing of billing is tied to contractual milestones. The Company adheres to such contractually stated performance milestones and accordingly issues invoices to customers as per contract billing schedules. Approximately ~~$7.6~~$8.9 million of deferred revenue is included in billed accounts receivable at March 31, ~~2015~~.2016. The Company recognized and recorded bad debt expense (benefit) in the amount of $9(241) thousand for the three-month periods ended March 31, 2016 and $9 thousand for the three-month period ended March 31, 2015 ~~and $353 thousand for the~~ ~~three-month period ended~~ ~~March 31, 2014, respectively.~~. Accounts receivable are written off against the allowance account when the Company has exhausted all reasonable collection efforts. During the three months ending March 31, 2016, $2.1 million of accounts receivable were written off.

Goodwill and Other Indefinite-Lived Intangible Assets—Goodwill represents the cost in excess of the fair value of the net assets of acquired businesses. Indefinite-lived intangible assets represent the fair value of certain acquired contractual customer

relationships for which future cash flows are expected to continue indefinitely. In accordance with the relevant FASB accounting guidance, goodwill and indefinite-lived intangible assets are not amortized but are tested for impairment at the reporting unit level on an annual basis or on an interim basis if an event occurs or circumstances change that would likely have reduced the fair value of a reporting unit below its carrying value. Potential impairment indicators include a significant change in the business climate,

~~Table of Contents~~

legal factors, operating performance indicators, competition, and the sale or disposition of a significant portion of the business. The impairment evaluation process involves an assessment of certain qualitative factors to determine whether the existence of events or circumstances would indicate that it is more likely than not that the fair value of any of our reporting units was less than its carrying amount. If after assessing the totality of events or circumstances, we were to determine that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company would not perform the two-step quantitative impairment testing described further below.

The aforementioned two-step quantitative testing process involves comparing the reporting unit carrying values to their respective fair values; we determine fair value of our reporting units by applying the discounted cash flow method using the present value of future estimated net cash flows. If the fair value of a reporting unit exceeds its carrying value, then no further testing is required. However, if a reporting unit's fair value were to be less than its carrying value, we would then determine the amount of the impairment charge, if any, which would be the amount that the carrying value of the reporting unit's goodwill exceeded its implied value. Projections of cash flows are based on our views of growth rates, operating costs, anticipated future economic conditions and the appropriate discount rates relative to risk and estimates of residual values. We believe that our estimates are consistent with assumptions that marketplace participants would use in their estimates of fair value. The use of different estimates or assumptions for our projected discounted cash flows (e.g., growth rates, future economic conditions, discount rates and estimates of terminal values) when determining the fair value of our reporting units could result in different values and may result in a goodwill impairment charge. We perform our annual goodwill impairment evaluation and testing as of September 30th of each year. This evaluation is done during the fourth quarter each year. During the year ended December 31, ~~2014~~2015 we had no impairment of our reporting unit goodwill balances.

Changes in the carrying amount of goodwill for the three months ended March 31, ~~2015~~2016 and the year ended December 31, ~~2014~~2015 are reflected in the following table.


	March 31, 2015			December 31, 2014			March 31, 2016		December 31, 2015
	(In thousands)						(In thousands)
Beginning Balance	$	402,220		$	337,068		$	402,259	$	402,220
Additions	—			68,503			—		8,868
Purchase accounting adjustments for prior year acquisitions							—		(2,099		)
Contributed portions of CurePet investment to Joint Venture, see Note 9, "Investment in Joint Venture"							—		(1,783		)
Foreign currency translation adjustments	(2,812		)	(3,351		)	951		(4,947		)
Ending Balance	$	399,408		$	402,220		$	403,210	$	402,259

Capitalized Software Development Costs—In accordance with the relevant FASB accounting guidance regarding the development of software to be sold, leased, or marketed, the Company expenses such costs as they are incurred until technological feasibility has been established, at and after which time those costs are capitalized until the product is available for general release to customers. Costs incurred to enhance our software products, after general market release of the services using the products, is expensed in the period they are incurred.

Finite-lived Intangible Assets—Purchased intangible assets represent the estimated acquisition date fair value of customer relationships, developed technology, trademarks and non-compete agreements obtained in connection with the businesses we acquire. We amortize these intangible assets on a straight-line basis over their estimated useful lives, as follows:



Category		Life (yrs)
Customer relationships		~~7-20~~7–20
Developed technology		3–12
Trademarks		3–15
Non-compete agreements		5
Backlog		1.2
Database		10

The carrying value of finite-lived and indefinite-lived intangible assets at March 31, ~~2015~~2016 and December 31, ~~2014~~2015 are as follows:

Amortization expense recognized in connection with acquired intangible assets was $~~1.8~~1.7 million for the three months ended March 31, ~~2015~~2016 and ~~$1.9~~$1.8 million for the three months ended March 31, ~~2014, respectively.~~2015.

Foreign Currency Translation—The functional currency for the Company's foreign subsidiaries in India and Singapore is the U.S. dollar because the intellectual property research and development activities is provided by its Singapore subsidiary, and the product development and information technology enabled services activities for the insurance industry is provided by its India subsidiary, both in support of Ebix's operating divisions across the world, are transacted in U.S. dollars.

The functional currency of the Company's other foreign subsidiaries is the local currency of the country in which the subsidiary operates. The assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at the rates of exchange at the balance sheet dates. Income and expense accounts are translated at the average exchange rates in effect during the period. Gains and losses resulting from translation adjustments are included as a component of accumulated other comprehensive income in the accompanying consolidated balance sheets, and are included in the condensed consolidated statements of comprehensive income. Foreign exchange transaction gains and losses that are derived from transactions denominated in a currency other than the subsidiary's functional currency are included in the determination of net income.

Income Taxes—Deferred income taxes are recorded to reflect the estimated future tax effects of differences between the financial statement and tax basis of assets, liabilities, operating losses, and tax credit carry forwards using the tax rates expected to be in effect when the temporary differences reverse. Valuation allowances, if any, are recorded to reduce deferred tax assets to the amount management considers more likely than not to be realized. Such valuation allowances are recorded for the portion of the deferred tax assets that are not expected to be realized based on the levels of historical taxable income and projections for future taxable income over the periods in which the temporary differences will be deductible.

The Company also applies FASB accounting guidance on accounting for uncertainty in income taxes positions. This guidance clarifies the accounting for uncertainty in income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. In this regard we recognize the tax benefit from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.

The Company has applied the provisions under FAS update No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry Forward, A Similar Tax Loss, or a Tax Credit Carry Forward Exists. Under these provisions, an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carry forward, a similar tax loss, or a tax credit carry forward in most cases. This

provision has been applied resulting in $341 thousand and $341 thousand of unrecognized tax benefits have been applied against NOL carry forward amounts as of March 31, 2016 and December 31, 2015, respectively.

Recent Relevant Accounting Pronouncements—The following is a brief discussion of recently released accounting pronouncements that are pertinent to the Company's business:

In ~~May 2014~~March 2016 the FASB issued Accounting Standards Update ~~("ASU")~~(ASU) No. ~~2014-09, "Revenue~~2016-08, "Revenue from Contracts with ~~Customers"~~Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)". The amendments relate to when another party, along with the Company, is involved in providing a good or service to a customer. Topic 606 Revenue from Contracts with Customers requires an entity to determine whether the nature of its promise is to provide that good or service to the customer (i.e., the entity is a principal) or to arrange for the good or service to be provided to the customer by the other party (i.e., the entity is an agent). The amendments are intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations by clarifying the following:

> An entity determines whether it is a principal or an agent for each specified good or service promised to a customer.

> An entity determines the nature of each specified good or service (e.g., whether it is a good, service, or a right to a good or service).

> When another entity is involved in providing goods or services to a customer, an entity that is a principal obtains control of: (a) a good or another asset from the other party that it then transfers to the customer; (b) a right to a service that will be performed by another party, which gives the entity the ability to direct that party to provide the service to the customer on the entity’s behalf; or (c) a good or service from the other party that it combines with other goods or services to provide the specified good or service to the customer.

> The purpose of the indicators in paragraph 606-10-55-39 is to support or assist in the assessment of control. The amendments in paragraph 606-10-55-39A clarify that the indicators may be more or less relevant to the control assessment and that one or more indicators may be more or less persuasive to the control assessment, depending on the facts and circumstances.

The effective date and transition of these amendments is the same as the effective date and transition of ASU 2014-09, Revenue from Contracts with Customers (Topic 606). Public entities should apply the amendments in ASU 2014-09 for annual reporting periods beginning after December 15, 2017, including interim reporting periods therein (i.e., January 1, 2018, for a calendar year entity). The Company will adopt this new technical accounting guidance at that time and does not expect its adoption to have a material effect on its result of operations or financial position.

In March 2016 the FASB issued ASU 2016-07 "Investments - Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting". The amendments affect all entities that have an investment that becomes qualified for the equity method of accounting as a result of an increase in the level of ownership interest or degree of influence. The amendments eliminate the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an investor must adjust the investment, results of operations, and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. The amendments require that the equity method investor add the cost of acquiring the additional interest in the investee to the current basis of the investor’s previously held interest and adopt the equity method of accounting as of the date the investment becomes qualified for equity method accounting. Therefore, upon qualifying for the equity method of accounting, no retroactive adjustment of the investment is required. The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. The amendments should be applied prospectively upon their effective date to increases in the level of ownership interest or degree of influence that result in the adoption of the equity method. Earlier application is permitted. The Company will adopt this new technical guidance in 2017, and has not yet determined the impact of its adoption.

In March 2016 the FASB issued ASU 2016-09 ", “Compensation - Stock Compensation (Topic 718)”. This amendment simplifies the requirements for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The amendments in this ASU are effective for annual periods beginning after December 31, 2016, and interim periods within those annual periods. The Company will adopt ASU in January 2017, but has not fully assessed the impact its adoption will have on the Company's results of operations or financial position.

In February 2016 the FASB's issued ASU 2016-02, "Leases (Topic 842)". This new accounting guidance is intended to improve financial reporting about leasing transactions. The ASU affects all companies and other organizations that lease assets such as real estate, airplanes, and manufacturing equipment. The ASU will require organizations that lease assets referred to as “Lessees” to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. An organization is to provide disclosures designed to enable users of financial statements to understand the amount, timing, and uncertainty of cash flows arising from leases. These disclosures include qualitative and quantitative requirements concerning additional information about the amounts recorded in the financial statements. Under the new guidance, a lessee will be required to recognize assets and liabilities for leases with lease terms of more than twelve months. Consistent with current GAAP, the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee primarily will depend on its classification as a finance or operating lease. However, unlike current GAAP which requires only capital leases to be recognized on the balance sheet the new ASU will require both types of leases (i.e. operating and capital) to be recognized on the balance sheet. The FASB lessee accounting model will continue to account for both types of leases. The capital lease will be accounted for in substantially the same manner as capital leases are accounted for under existing GAAP. The operating lease will be accounted for in a manner similar to operating leases under existing GAAP, except that lessees will recognize a lease liability and a lease asset for all of those leases. The leasing standard will be effective for calendar year-end public companies beginning after December 15, 2018. Public companies will be required to adopt the new leasing standard for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted for all companies and organizations. For calendar year-end public companies, this means an adoption date of January 1, 2019 and retrospective application to previously issued annual and interim financial statements for 2018 and 2017. Lessees with a large portfolio of leases are likely to see a significant increase in balance sheet assets and liabilities. See Note 5 for the Company’s current lease commitments. The Company is in the process of evaluating the impact that this new leasing ASU will have on its financial statements.

In September 2015 the FASB issued ASU No. 2015-16, "Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments". This pronouncement simplifies the accounting for adjustments made to provisional amounts recognized in a business combination, the amendments eliminate the requirement to retrospectively account for those adjustments.

U.S. GAAP currently requires that during the measurement period, the acquirer retrospectively adjust the provisional amounts recognized at the acquisition date with a corresponding adjustment to goodwill. Those adjustments are required when new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts initially recognized or would have resulted in the recognition of additional assets or liabilities. The acquirer also must revise comparative information for prior periods presented in financial statements as needed, including revising depreciation, amortization, or other income effects as a result of changes made to provisional amounts.

The amendments require that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The amendments require that the acquirer record and disclose, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. The amendments require an entity to present separately on the face of the income statement or disclose in the notes the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date.

For public business entities, the amendments are effective for fiscal years beginning after December 15, 2015, including interim periods within those fiscal years. The amendments should be applied prospectively to adjustments to provisional amounts that occur after the effective date with earlier application permitted for financial statements that have not been issued. The only disclosures required at transition should be the nature of and reason for the change in accounting principle. An entity should disclose that information in the first annual period of adoption and in the interim periods within the first annual period if there is a measurement-period adjustment during the first annual period in which the changes are effective. The Company adopted this ASU during the third quarter of 2015 and its adoption did not have a material impact on its financial statements.

In November 2015, the FASB issued Accounting Standards Update No. 2015-17, Balance Sheet Classification of Deferred Taxes, or ASU 2015-17. This amendment requires that all deferred tax assets and liabilities, along with any related valuation allowance, be classified as noncurrent on the balance sheet. Prior to the issuance of ASU 2015-17, deferred taxes were required to be presented as a net current asset or liability and a net noncurrent asset or liability. We adopted the provisions of ASU 2015-17 upon issuance and prior period amounts have been reclassified to conform to the current period presentation. As of December 31, 2014, the previously reported balance of our net current deferred tax assets of $2.11 million was reclassified in the consolidated balance sheet and netted against the net long-term deferred tax liabilities. The adoption of ASU 2015-17 did not impact our consolidated financial position, results of operations or cash flows.

In May 2014 the FASB issued ASU No. 2014-09, "Revenue from Contracts with Customers". ASU 2014-09 affects any entity using U.S. GAAP that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). This ASU will supersede the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance. This ASU also supersedes some cost guidance included in Subtopic 605-35, Revenue Recognition—Construction-Type and Production-Type Contracts. In addition, the existing requirements for the

recognition of a gain or loss on the transfer of nonfinancial assets that are not in a contract with a customer (e.g., assets within the scope of Topic 360, Property, Plant, and Equipment, and intangible assets within the scope of Topic 350, Intangibles—Goodwill and Other) are amended to be consistent with the guidance on recognition and measurement (including the constraint on revenue) in this ASU.

The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps:

Step 1: Identify the contract(s) with a customer.

Step 2: Identify the performance obligations in the contract.

Step 3: Determine the transaction price.

Step 4: Allocate the transaction price to the performance obligations in the contract.

Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.

For a public entity, the amendments in this ASU are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted.

An entity should apply the amendments in this ASU using one of the following two methods:

1. Retrospectively to each prior reporting period presented and the entity may elect any of the following practical expedients:

2. Retrospectively with the cumulative effect of initially applying this ASU recognized at the date of initial application. If an entity elects this transition method it also should provide the additional disclosures in reporting periods that include the date of initial application of:

~~The~~Subsequently in August 2015 the FASB issued ASU No. 2015-14 "Revenue from Contracts with Customers: Deferral of Effective Date", to defer the effective date of ASU No. 2014-09 for all entities by one year. Accordingly public business entities should apply the guidance of ASU No. 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that annual reporting period.

Although early adoption is allowed, the Company ~~currently expects~~plans to adopt this new accounting standard on its newly revised effective date ~~currently~~of January 1, ~~2017, and~~2018, but it has not presently determined the impact that the adoption of ASU No. 2014-09 will have on its income statement, balance sheet, or statement of cash flows. Furthermore, the Company has not yet determined the method of retrospective adoption it will use as described in ~~paragraphs 1~~first and 2second paragraphs immediately above.

~~In July 2013,~~Furthermore, in a related technical accounting pronouncement in April 2016 the FASB issued ~~Accounting Standards Update No. 2013-11, "Presentation~~ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing”, which is an amendment to ASU 2014-09. This amendment provides clarification on two aspects of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists". This accounting standard states that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use,Topic 606: identifying performance obligations and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets.licensing implementation guidance. This accounting standards update applies to all entities that have unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. The accounting standards update is effective for ~~fiscal years,~~annual reporting periods beginning on or after December 15, 2016 and interim periods ~~within those years, beginning after December 15, 2013. This pronouncement should be applied prospectively to all unrecognized tax benefits that exist at~~therein and requires expanded disclosures; however, the FASB has approved the idea of deferring the effective date. Retrospective application is permitted. The Company adopted this new standard during the interim three-month reporting period ending March 31, 2014, and it materially effected how unrecognized tax benefits were accounteddate for ~~and presented in the Company's balance sheet.~~one year.

Note 2: Earnings per Share

A reconciliation between basic and diluted earnings per share is as follows (in thousands, except per share data):



	Three Months Ended
	March 31,
	2016		2015
	(In thousands, except per share data)
Net income attributable to Ebix, Inc.	$	22,159	$	18,336
Basic Weighted Average Shares Outstanding	33,043		35,708
Dilutive effect of stock options and restricted stock awards	267		246
Diluted weighted average shares outstanding	33,310		35,954
Basic earnings per common share	$	0.67	$	0.51
Diluted earnings per common share	$	0.67	$	0.51

Three Months Ended
March 31,
2015 2014
(In thousands, except per share data)
Net income for basic and diluted earnings per share $ 18,336
$ 15,417
Basic Weighted Average Shares Outstanding 35,708
38,318
Dilutive effect of stock options and restricted stock awards 246
282
Diluted weighted average shares outstanding 35,954
38,600
Basic earnings per common share $ 0.51
$ 0.40
Diluted earnings per common share $ 0.51
$ 0.40

Note 3: Business Combinations

The Company seeks to execute accretive business acquisitions in combination with organic growth initiatives as part of its comprehensive business growth and expansion ~~strategy. The Company looks to acquire~~strategy, which primarily consist of businesses that are complementary to Ebix's existing products and services.

During the three months ended March 31, 2016 the Company did not have any business acquisitions.

During the year ended December 31, 2015, the Company completed ~~one~~two business acquisitions, as follows:

The Company acquired PB Systems, Inc. and PB Systems Private Limited (together being "PB Systems"), effective June 1, 2015. PB Systems develops and implements software solutions for insurance clients. Ebix acquired PB Systems for upfront cash consideration in the amount of $12.4 million, plus possible future contingent earn out payments of up to $8.0 million based on earned revenues over the subsequent twenty-four month period following the effective date of the acquisition. The Company has determined that the fair value of the contingent earn out consideration is $990 thousand as of March 31, 2016. The valuation and purchase price allocation for the PB Systems acquisition remains preliminary.

The Company acquired Via Media Health Communications Private Limited ("Via Media Health"), effective March 1, 2015. Via Media Health is one of India’s leading health content and communication companies. Ebix acquired Via Media Health for upfront cash consideration in the amount of $1.0 million, plus a possible future one time contingent ~~earnout~~earn out payment of up to $372 thousand based on earned revenues over the subsequent twelve month period following the effective date of the acquisition, and aan additional possible one time future performance bonus of up to $1.0 million depending upon revenue growth realized in the business over the subsequent twenty-four month period following the effective date of the acquisition. The ~~valuation and purchase price allocation for~~Company has determined that the Via Media Health acquisition remains preliminary and will be finalized prior to June 30, 2015, and accordingly the contingent earnout liability in connection with this acquisition has not been recorded.

Effective December 2, 2014, Ebix acquired Oakstone Publishing, LLC ("Oakstone") in a membership interest purchase agreement for total net cash consideration in the amount of $23.72 million ($31.37 million less a closing net working capital adjustment of $7.65 million). Oakstone is leading provider of continuing education, certification materials for physicians, dentists and allied healthcare professionals, as well as wellness resources for various organizations. Ebix acquired all of the outstanding membership interests of Oakstone and funded the purchase using a mix of internal cash reserves and the bank credit line available to Ebix. The Company accounted for this acquisition by recording $28.8 million of goodwill, $1.7 million of intangible assets pertaining to customer relationships, $501 thousand of intangible assets pertaining to acquired technology, and a $6.5 million deferred revenue liability. The valuation and purchase price allocation for the Oakstone acquisition remains preliminary and will be finalized prior to June 30, 2015.

On December 1, 2014, Ebix acquired the DCM Group Inc. (d.b.a. i3 Software) ("i3") in an asset purchase agreement for total cash consideration in the amount of $2 million and a possible contingent earnout of up to $4 million based on earned revenues over the subsequent twenty-four month period following the date of the acquisition. i3 is a provider of software services and solutions to the insurance industry. Ebix acquired all of the assets of i3 and funded the purchase using internal cash reserves. The Company accounted for this acquisition by recording $3.7 million of goodwill, $225 thousand of intangible assets pertaining to customer relationships, and $75 thousand of intangible assets pertaining to acquired technology. The valuation and purchase price allocation for the i3 acquisition remains preliminary and will be finalized prior to June 30, 2015.

OnNovember 3, 2014, Ebix acquired Vertex, Incorporated ("Vertex"), with an effective date of October 1, 2014, in a share purchase agreement for total cash purchase consideration in the amount of $27.25 million and a possible contingent earnout of $2 million based on earned revenues over the subsequent twenty-four month period following the date of the acquisition. Vertex is a specialized software and services firm focused primarily on the life and annuity insurance marketplace since 1991. Ebix acquired all of the outstanding capital stock of Vertex and funded the purchase using a mix of internal cash reserves and the bank credit line available to Ebix. The Company accounted for this acquisition by recording $27.7 million of goodwill, $2.5 million of intangible assets pertaining to customer relationships, and $235 thousand of intangible assets pertaining to acquired technology. The valuation and purchase price allocation for the Vertex acquisition remains preliminary and will be finalized prior to June 30, 2015.

On May 21, 2014, Ebix acquired HealthCare Magic Private Limited ("HealthCare Magic"), a medical advisory service with an online network of approximately fifteen thousand General Physicians and Surgeons spread across fifty specialties including alternative medicine. The Company acquired HealthCare Magic for aggregate cash consideration in the amount of $6.0 million plus a possible future one time contingent earnout payment of up to $12.36 million based on earned revenues over the subsequent twenty-four month period following the effective date of the acquisition. This contingent earnout liability is currently estimated to have a fair value of ~~$596 thousand. The Company funded~~ the ~~HealthCare Magic acquisition from available cash reserves on hand. The Company accounted for this acquisition by recording $5.6 million~~contingent earn out consideration is $955 thousand as of goodwill, $452 thousand of intangible assets pertaining to customer relationships, $100 thousand of intangible assets pertaining to acquired technology, $59 thousand on intangible assets pertaining to trademarks and tradenames, and $226 thousand of intangible assets pertaining to non-compete agreements.

On January 27, 2014, Ebix acquired CurePet. CurePet was a developmental-stage enterprise that developed an insurance exchange that connects pet owners, referring veterinarians, animal hospitals, academic institutes, and suppliers of medical and general pet supplies, while providing a wide variety of services related to pet insurance to each constituent including practice management, electronic medical records, and billing. Previously Ebix had a minority investment in CurePet. Ebix acquired the entire business of CurePet in an asset purchase agreement with total purchase consideration being $6.35 million which includes a possible future one time contingent earnout payment of up to $5.0 million based on earned revenues over the subsequent thirty-six month period following the effective date of the acquisition. This contingent earnout liability is currently estimated to have a fair value of zero. Additional required cash consideration of $1.35 million was offset against open accounts receivable balances due to the Company from CurePet, and no actual cash outlay was made by the Company.March 31, 2016.

A significant component of the purchase price consideration for many of the Company's business acquisitions is a potential subsequent cash earnout payment based on reaching certain specified future revenue targets. The terms for the contingent earn out payments in most of the Company's business acquisitions typically address the GAAP recognizable revenues achieved by the acquired entity over a one, two, and/or three year period subsequent to the effective date of their acquisition by Ebix. These terms typically establish a minimum threshold revenue target with achievement of revenues recognized over that target being awarded in the form of a specified earn out payment. The Company applies these terms in its calculation and determination of the fair value of contingent earn out liabilities for purchased businesses as part of the related valuation and purchase price allocation exercise for the corresponding acquired assets and liabilities. The Company recognizes these potential obligations as contingent liabilities and are reported accordingly on its Condensed Consolidated Balance Sheets. As discussed in more detail in Note 1, these contingent consideration liabilities are recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. During the three months ended March 31, ~~2015~~2016 and ~~2014~~2015 these aggregate contingent accrued earn-out business acquisition consideration liabilities were reduced by ~~zero~~$511 and ~~$1.8 million,~~zero, respectively, due to remeasurements as based on the then assessed fair value and changes in anticipated future revenue levels. These reductions to the contingent accrued

The aggregated unaudited pro forma financial information pertaining to all of the Company's acquisitions made during the three months ended March 31, ~~2014~~2015 and March 31, ~~2015,~~2016, which includes the acquisitions of ~~CurePet (acquired in January 2014), and~~ Via Media Health (acquired in March 2015), ~~as well as the effect of other businesses acquired in 2014, namely HealthCare Magic (May 2014), Vertex (October 2014), Oakstone (December 2014),~~ and ~~i3 (December 2014)~~PB Systems (acquired June 2015), as presented in the table below is provided for informational purposes only and ~~does~~is not ~~project~~a projection of the Company's expected results of operations for any future period. No effect has been given in this pro forma information for future synergistic benefits that may still be realized as a result of combining these companies or costs that may yet be incurred in integrating their operations. The ~~2015~~2016 and ~~2014~~2015 pro forma financial information below assumes that all such business acquisitions were made on January 1, ~~2014,~~2015, whereas the Company's

reported financial statements for the three months ended March 31, ~~2015~~2016 only include the operating results from these businesses since the effective date that they were acquired by Ebix.

~~In the above table, the unaudited pro forma revenue for~~During the three months ended March 31, 2016 the Company's reported total operating revenues increased by $7.3 million or 11% to $71.1 million as compared to $63.8 million during the first quarter of 2015. Reported revenues were effected by the continuing weakening in the foreign currencies in which we conduct operations (particularly in Australia, Brazil, Great Britain, and India) as compared to the strengthening of the U.S. dollar. Specifically, the adverse impact from fluctuations of the exchange rates for the foreign currencies in the countries in which we conduct operations, in the aggregate reduced reported revenues in the 1st quarter of 2016 by $1.8 million.

With respect to business acquisitions completed during the years 2016 and 2015 ~~decreased by $1.3 million from the unaudited~~on a pro forma ~~revenue during~~basis, as disclosed in the above “Pro Forma Financial Information”, combined revenues increased 7% for the first quarter of 2016 versus the same period in ~~2014 of $65.3 million to $64.0 million, representing a 2.0% decrease. Correspondingly,~~2015. The 2016 and 2015 pro forma financial information assumes that all business acquisitions made during this period were made on January 1, 2015, whereas the Company's reported ~~revenue~~financial statements for Q1 2016 and Q1 2015 only includes the ~~three months ended~~revenues from these businesses since the effective date that they were acquired by Ebix, being March ~~31,~~ 2015 ~~increased by $12.3 million or 24.0% from~~for Via Media Health, and June 2015 for PB Systems.

The above referenced pro forma information and the relative comparative change in pro forma and reported ~~revenue during~~revenues are based on the ~~same period in 2014. The~~following premises:

•2016 and 2015 pro forma revenue ~~decrease was primarily due~~contains actual revenue of the acquired entities before acquisition date, as reported by the sellers, as well as actual revenue of the acquired entities after acquisition. Whereas the reported growth in revenues of the acquired entities after acquisition date are only reflected for the period after their acquisition.

•Revenue billed to ~~exchange rate changes which resulted~~existing clients from the cross selling of acquired products has been assigned to the acquired section of our business.

•Any existing products sold to new customers obtained through a newly acquired customer base, are assigned to the acquired section of our business.

•Pro formas do not include post acquisition revenue reductions as a result of discontinuation of any product lines and/or customer projects by Ebix in ~~a decrease of $1.9 million.~~its bid to maximize profitability.

Note 4: Debt with Commercial Bank

Effective October 14, 2015 Ebix, in coordination with Regions Financial Corporation ("Regions") as administrative agent and a joint lender, exercised the $50 million accordion feature in the existing Regions Secured Syndicated Credit Facility thereby expanding the total credit facility to $240 million. As part of this credit facility expansion, TD Bank, NA ("TD") was added to the syndication group along with five other bank participants, which include Regions, MUFG Union Bank N.A., Fifth Third Bank, and Silicon Valley Bank as joint lenders. TD commitment level is $25 million. The expanded credit facility will continue to be used to fund the Company's future organic and acquisitive growth plans, and share repurchase initiatives.

On February 3, 2015, Ebix ~~Inc. and certain of its subsidiaries~~ entered into the First Amendment (the “First Amendment”) to the Regions Secured Credit Facility, dated August 5, 2014, among the Company, Regions Financial Corporation as Administrative Agent (“Regions”), with Regions, MUFG Union Bank N.A., and Silicon Valley Bank as joint lenders. The First Amendment ~~amends~~amended the Regions Credit Facility by increasing the maximum amount by which the Aggregate Revolving Commitments may be increased to $90 million from the pre-existing limit of $50 million, ~~increases~~increasing the amount of base facility to $190 million from the pre-existing amount of $150 million, which together with the $50 million accordion feature ~~increases~~increased the total Credit Agreement capacity amount to $240 million from the prior amount of $200 million, and expands the syndicated bank group to four participants by adding Fifth Third Bank.

On August 5, 2014, Ebix entered into a credit agreement providing for a $150 million secured syndicated credit facility (the “Regions Secured Credit Facility”) with Regions as administrative agent and Regions with MUFG Union Bank N.A., and Silicon Valley Bank as joint lenders. The financing iswas comprised of a five-year, $150 million secured revolving credit facility, with an option to expand to $200 million upon request and with additional lender commitments. This new $150 million credit facility with Regions, as administrative agent, replaced the former syndicated $100 million facility that the Company had in place with Citi Bank, N.A. which was paid in full upon the undertaking of this new loan facility with Regions. The interest rate applicable to the Secured Syndicated Credit Facility is LIBOR plus 1.50% ~~or currently 1.69%~~. Under the Regions Secured Credit Facility the maximum interest rate that could be charged depending upon the Company's leverage ratio is LIBOR plus 2.25%. The underlying financing agreement contains financial covenants regarding the Company's fixed charge coverage ratio and leverage ratio, as well as certain restrictive covenants pertaining to such matters as the incurrence of new debt and the consummation of new business acquisitions. The Company currently is in compliance with all such financial and restrictive covenants. As of March 31, ~~2015~~2016 the Company's consolidated balance sheet includes $1.50 million of remaining deferred financing ~~costs.~~costs in connection with this credit facility.

At March 31, ~~2015,~~2016, the outstanding balance on the revolving line of credit under the Regions Secured Credit Facility was ~~$135.5~~$226.5 million and the facility carried an interest rate of ~~1.69%~~2.50%. During the three months ended March 31, ~~2015,~~2016, $20.0 million of draws were made off of the revolving credit facility, and no payments were made against the revolving line of ~~credit during the quarter.~~credit. The revolving line of credit balance is included in the long-term liabilities section of the Condensed Consolidated Balance Sheets. During the three months period ended March 31, ~~2015,~~2016, the average and maximum outstanding balances on our revolving line of credit facilities were ~~$127.4~~$209.8 million and ~~$135.5~~$226.5 million, respectively.

Note 5: Commitments and Contingencies

Contingencies-On December 3, 2012, the Company received a subpoena and letter from the ~~SEC~~Securities and Exchange Commission (“SEC”) dated November 30, 2012, stating that the SEC is conducting a formal, non-public investigation styled In the Matter of Ebix, Inc. (A-3318) and seeking documents primarily related to the issues raised in the In re: Ebix, Inc. Securities Litigation. On April 16, 2013, the Company received a second subpoena from the SEC seeking additional documents. The Company has cooperated with the SEC to provide the requested documents.

On June 6, 2013, the Company was notified that the U.S. Attorney for the Northern District of Georgia had opened an investigation into allegations of intentional misconduct that had been brought to its attention from the pending shareholder class action lawsuit against the Company's directors and officers, the media and other sources. The Company is cooperating with the U.S. Attorney's office.

Following ~~our~~the announcement on May 1, 2013 of the Company's execution of a merger agreement with affiliates of

Goldman Sachs & Co., twelve putative class action complaints challenging the proposed merger were filed in the Delaware Court of Chancery. These complaints name as Defendants some combination of the Company, its directors, Goldman Sachs & Co. and affiliated entities. On June 10, 2013, the twelve complaints were consolidated by the Delaware Court of Chancery, now captioned In re Ebix, Inc. Stockholder Litigation, CA No. 8526-VCN. On June 19, 2013, the Company announced that the merger agreement had been terminated pursuant to a Termination and Settlement ~~Agreement.~~Agreement dated June 19, 2013. After Defendants moved to dismiss the consolidated proceeding, Lead Plaintiffs amended their operative complaint to drop their claims against Goldman Sachs & Co. and focus their allegations on an Acquisition Bonus Agreement (“ABA”) between the Company and Robin Raina. On September 26, 2013, Defendants moved to dismiss the Amended Consolidated Complaint. On July 24, 2014, the Court issued its Memorandum ~~Opinion. The only surviving counts are as follows: (i) Counts II and IV, but only to the extent the Plaintiffs seek non-monetary relief for alleged material misstatements related to the ABA base price~~Opinion that granted in the 2010 Proxy Statement; (ii) Count II, but only to the extent it challenges the continued existence of the ABA as an alleged unreasonable anti-takeover device; and, (iii) Count V, but only to the extent that it relates to the compensation the Board received underlarge part the Company’s ~~2010 Stock Incentive Plan.~~Motion to Dismiss and narrowed the remaining claims. On September 15, 2014, the Court entered an Order implementing its Memorandum Opinion. On January 16, 2015, the Court entered an Order permitting Plaintiffs to file a Second Amended and Supplemented Complaint. On February 10, 2015, Defendants filed a Motion to Dismiss the Second Amended and Supplemented Complaint, which ~~is pending.~~was granted in part and denied in part in a January 15, 2016 Memorandum Opinion and Order. The remaining claims are as follows: (i) a purported class and derivative claim for breach of fiduciary duty by the individual Defendants for improperly maintaining the ABA as an unreasonable anti-takeover device; (ii) a purported class claim against the individual Defendants for breach of the fiduciary duty of disclosure to the stockholders with respect to the Company’s 2010 Proxy Statement and 2010 Stock Incentive Plan, (iii) a purported derivative claim against the individual Defendants for breach of fiduciary duty to the Company in causing incentive compensation to be awarded to themselves and others under the 2010 Stock Incentive Plan, (iv) a purported class and derivative claim for breach of fiduciary duty by the individual Defendants in adopting certain bylaw amendments on December 19, 2014, and (v) a purported class and derivative claim seeking invalidation of the December 19, 2014 bylaw amendments under Delaware law. Lead Plaintiffs seek declaratory relief with respect to the 2010 Stock Incentive Plan, the 2010 Proxy Statement, and the bylaw amendments. Lead Plaintiffs also seek compensatory damages, interest, and attorneys’ fees and costs.The parties have filed answers to the remaining claims in the Second Amended and Supplemented Complaint and discovery has commenced. The Company denies any liability and intends to defend the action vigorously.

The Company is involved in various other claims and legal actions arising in the ordinary course of business. In the opinion of management, the ultimate likely disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position, results of operations or liquidity.

Lease Commitments—The Company leases office space under non-cancelable operating leases with expiration dates ranging through 2021, with various renewal options. Capital leases range from three to five years and are primarily for computer equipment. There were multiple assets under various individual capital leases at March 31, ~~2015~~2016 and ~~2014~~2015. Rental expense for office facilities and certain equipment subject to operating leases for the three months ended March 31, ~~2015~~2016 and ~~2014~~2015 was $~~1.7~~1.5 million and $~~1.6~~1.7 million, respectively.

Self Insurance—For ~~most~~some of the Company’s U.S. employees the Company is self-insured for its health insurance program and has a stop loss policy that limits the individual liability to ~~$120~~$120 thousand per person and the aggregate liability to 125% of the expected claims based upon the number of participants and historical claims. As of March 31, ~~2015~~,2016, the amount accrued on the Company’s Condensed Consolidated Balance Sheet for the self-insured component of the Company’s employee health insurance was ~~$250 thousand~~.$276 thousand. The maximum potential estimated cumulative liability for the annual contract period, which ends in September ~~2015,~~2016, is ~~$2.9 million~~.$2.9 million.

Note 6: Income Taxes

The Company recorded income tax expense of $1.8 million (7.3%) and $2.4 million (11.60%) during the three months ended March 31, 2016 and 2015, respectively, which included discrete items for prior year true-ups that resulted in a net charge of $687 thousand and zero for those same respective periods. The Company's ~~consolidated world-wide~~tax expense and effective tax rate decreased year over year, exclusive of discrete charges, due to favorable changes in the proportion of our taxable income in certain low tax rate foreign jurisdictions relative to total pre-tax income. The Company expects its full year effective tax rate to be approximately 7.7%.

The Company’s effective tax rate reflects the ~~tax~~ benefits of ~~conducting operating activities in certain foreign jurisdictions where earnings~~having significant operations outside the United States, which are taxed at rates lower than ~~U.S.~~the US statutory ~~rates~~rate of 35% and ~~where certain components of~~also due to the ~~Company's income are exempt from taxation. Furthermore,~~fact that the ~~Company's world-wide product development operations and intellectual property ownership have been centralized into our India and Singapore subsidiaries. Our operations in India benefit from~~Company enjoys a tax holiday ~~which affects various operating facilities~~in India. During 2015, the Company secured an additional tax holiday in India until the year 2020 to support certain portions of its expanding operations in that country. The Company ~~has many facilities in India with each one having a different tax holiday expiration date between 2015 and 2018. As such a significant component of~~had income during the income generated by our India operations, other than passive interest income, is not taxed. After the expiration of the full tax holiday all of the income generated by our India operations will be taxed at ~~50%~~ ~~of the normal~~ ~~33.99%~~ ~~corporate tax rate for a period of~~ ~~five~~ ~~years.~~

~~The Company recognized total income tax expense in the amount of $2.40 million for the three months~~quarter ended March 31, 2015. The Company's interim period income tax provisions are based on a calculated estimate of the effective income tax rate expected to be applicable to the corresponding annual period, after eliminating discrete items unique to the respective interim period being reported. The Company's interim period tax provision, exclusive of discrete items, for the three month period during 2015 reflects an effective tax rate of 11.43%, as compared to the 12.01%, also exclusive of discrete items, for the same period during 2014. The effective rate decreased slightly due to less taxable income from jurisdictions with higher tax rates.

At March 31, 2015, the Company had remaining available domestic net operating loss (“NOL”) carry-forwards of approximately $41.2 million which are available to offset future U.S. federal and certain state income taxes. In addition the Company has approximately $41.4 million of NOL's available2016 in Singapore, the United Kingdom ~~related to~~and Sweden, where the ~~2013 acquisition~~statutory tax rates are lower than the US rate of Qatarlyst to offset future taxable income in that country. There is currently a full valuation allowance set up against 100% of these NOL’s in the United Kingdom. The Company reviews its NOL positions to validate that all NOL carry-forwards will be utilized before they begin to expire in 2020.

The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction, and various states and foreign jurisdictions in which it conducts operations or had nexus. With the exception of NOL carry forwards, the Company is no longer subject to U.S. federal or state tax examinations by tax authorities for years before 2013. Regarding our foreign operations as of December 31, 2014, the tax years that remain open and possibly subject to examination by the tax authorities in those jurisdictions are Australia (2008 to 2013), Singapore and Brazil (2008 to 2013), New Zealand (2010 to 2013), and India (2009 to 2013)35%.

~~Accounting for Uncertainty in Income Taxes—The Company has applied the FASB’s accounting guidance on accounting for uncertain income tax positions.~~ As of March 31, ~~2015 the Company’s Condensed Consolidated Balance Sheet includes~~2016 a liability of ~~$3.11~~$3.2 million for ~~unrecognized~~uncertain tax ~~benefits which~~positions is included in other ~~long term~~long-term liabilities ~~before applying~~of the ~~offset provision required by the application of Notice 2013-11.~~Company's Condensed Consolidated Balance Sheet. During the three months ended March 31, 2016 and 2015 there was $50 thousand and $87 thousand, respectively, in additions to this liability ~~reserve. A reconciliation of the beginning~~reserve for additional estimated interest and ~~ending amounts of the Company’s liability reserves for unrecognized tax benefits is as follows:~~

March 31, 2015 December 31, 2014
(in thousands)
Beginning Balance $ 3,020
$ 12,742
Additions for tax positions related to current year —
451
Additions for tax positions of prior years 87
9,348
Reductions for tax position of prior years —
(19,521 )
Ending Balance $ 3,107
$ 3,020

penalties. The Company recognizes interest accrued and penalties related to unrecognized tax benefits as part of income tax expense. ~~As of March~~

At December 31, 2015 ~~and December 31, 2014 approximately $767 thousand and $680 thousand, respectively, of estimated interest and penalties is included in other long term liabilities in~~ the ~~accompanying Condensed Consolidated Balance Sheet, and is part~~cumulative amount of the ~~balance of the liability for unrecognized tax benefits in the above table.~~

The Company has applied the new provisions under FAS update No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, A Similar Tax Loss, or a Tax Credit Carryforward Exists. Under these provisions, an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward in most cases. This provision has been applied and $929 thousand and $1.14 million of unrecognized tax benefits have been applied against NOL carryforward amounts as of March 31, 2015 and December 31, 2014, respectively.

Company’s undistributed foreign earnings was $354.2 million.

Note 7: Geographic Information

The Company operates with one reportable segment whose results are regularly reviewed by the Company's chief operating decision maker as to performance and allocation of resources. External customer revenues in the tables below are attributed to a particular country based on whether the customer had a direct contract with the Company which was executed in that particular country for the sale of the Company's products/services with an Ebix subsidiary located in that country.

The impact from fluctuations of the exchange rates for the foreign currencies in the countries in which we conduct operations partially affected reported revenues, and were the primary cause for the drop in 2016 revenues in Australia and Brazil. Specifically, during the first quarter of 2016 the change in foreign currency exchange rates decreased reported Australian operating revenues by ($708) thousand and Brazilian operating revenues by$(422) thousand. India's first quarter of 2016 operating revenues increased $1.5 million due to the new e-governance contract.

The following enterprise wide information relates to the Company's geographic locations (all amounts in thousands):

Note 8: ~~Minority Business~~ Investment in Joint Ventures

~~In 2012,~~Effective September 1, 2015 Ebix ~~acquired~~and Independence Holdings Corporation ("IHC") formed a ~~minority 19.8%~~joint venture named Ebix Health Exchange Holdings, LLC ("EbixHealth JV"). This joint venture was established to promote and market a best practices administration data exchange for health and pet insurance lines of business nationally. Ebix paid $6.0 million and contributed a license to use certain CurePet software and systems valued by the EbixHealth JV at $2.0 million, for its 40% membership interest in ~~CurePet~~the EbixHealth JV. IHC contributed all if its shares in its existing third party administrator operations (IHC Health Solutions, Inc.), valued by the EbixHealth JV at $18.0 million for ~~cash consideration~~its 60% membership interest in the ~~amount of $2.0 million. CurePet is a developmental-stage enterprise that developed an insurance exchange that connects pet owners, referring veterinarians, animal hospitals, academic institutes,~~EbixHealth JV. Furthermore IHC also has been and ~~suppliers of medical and general pet supplies, while providing a wide variety of services related~~continues to ~~pet insurance to each constituent including practice management, electronic medical records, and billing. CurePet had previously been~~be a customer of ~~Ebix;~~Ebix, and during ~~2013 and 2012~~the three months ending March 31, 2016 the Company recognized ~~$1.2 million and $1.5 million, respectively,~~$857 thousand of revenue from CurePet. Ebix also had a revenue share arrangement with CurePet pertaining to certain customer revenues recognized by CurePet; for 2015, there have been no revenue sharing earned or accrued. The Company had been accounting for its minority investment in CurePet using the cost method. Based on this independent evaluation it was concluded that the fair value of this minority business investment was greater than the Company's carrying value of the investment,IHC and ~~therefore the investment was not impaired~~ as of ~~December~~March 31, ~~2013. As disclosed in Note 3 "Business Combinations," effective January 27, 2014~~2016 IHC had $136 thousand of accounts receivables with Ebix. In addition, Ebix ~~acquired~~is rendering services to the ~~entire business of CurePet in an asset purchase agreement with the total purchase consideration being in the amount of $6.35 million which included~~EbixHealth JV as a possible contingent earnout payment of up to $5.0 million based on earned revenues over the subsequent thirty-six month period following the date of the acquisition. This contingent earnout liability is currently estimated to have a fair value of zero.customer. During the three months ~~ended~~ending March 31, ~~2015 and 2014~~2016 the ~~CurePet business generated $0 and $125~~Company recognized $372 thousand ~~respectively,~~ of revenue ~~which~~from the EbixHealth JV. Ebix is ~~included~~accounting for the investment in the ~~Company’s consolidated revenues reported for~~EbixHealth JV using the ~~same period.~~equity method whereby 40% of the EbixHealth JV periodic profits or losses will be recognized in Ebix's financial statements, after December 16, 2016.

Effective February 7, 2016 Ebix and Vayam Technologies Ltd ("Vayam") formed a joint venture named Ebix Vayam Limited JV. This joint venture was established to carry out IT projects in the government sector of the country of India and particularly in regards to the implementation of e-governance projects in the areas of education and healthcare. Ebix has a 51% equity interest in the joint venture and Vayam has a 49% equity interest in the joint venture. Ebix is fully consolidating the operations of the Ebix Vayam Limited JV into the Company's financial statements and separately reporting Vayam minority, non-controlling, interest in the joint venture's net income and equity.

Note 9: Other Liabilities

Other liabilities at March 31, ~~2015~~2016 and December 31, ~~2014~~2015 consisted of the following:

Note 10: Capitalized Software Development Costs

In accordance with the relevant authoritative accounting literature the Company has capitalized certain software and product related development costs associated with both the Company’s continuing medical education service offerings, and the Company’s recent development of its property and casualty underwriting insurance data exchange platform. During three months ended March 31, 2016, the Company capitalized $144 thousand of such development costs. As of March 31, 2016, a total of $3.2 million of remaining unamortized development costs are reported on the Company’s consolidated balance sheet. During the three months ended March 31, 2016, the Company recognized $326 thousand of amortization expense with regards to these capitalized software development costs, which is included in costs of services provided in the Company’s consolidated income statement. The useful life over which these capitalized software development costs are being amortized is eighteen months for the continuing medical education products, and six years for the property and casualty underwriting insurance data exchange platform.

Note 11: Other Current Assets

Other current assets at March 31, 2016 and December 31, 2015 consisted of the following:



	March 31, 2016		December 31, 2015
	(In thousands)
Prepaid expenses	$	8,527	$	8,290
Sales taxes receivable from customers	89		120
Due from prior owners of acquired businesses for working capital settlements	997		1,021
Research and development tax credits receivable	514		898
Payroll taxes overpayment receivable	640		—
Other	656		613
Total	$	11,423	$	10,942

Note ~~10:~~12: Subsequent Events

Repurchases of Common Stock

Since December 31, ~~2014~~2015 and through March 31, ~~2015~~2016 the Company repurchased ~~994,869~~465,560 shares of its outstanding common stock for aggregate cash consideration in the amount of ~~$24.2~~$14.0 million and at an average rate of ~~$24.35~~$30.00 per share. Subsequent to March 31^st31st and through May ~~7, 2015~~6, 2016 the Company has re-purchased an additional ~~289,365~~217,487 shares of its outstanding common stock for aggregate cash consideration in the amount of ~~$8.1~~$9.1 million and at an average rate of ~~$28.13~~$42.02 per share. All share repurchases were done in accordance with Rule 10b-18 of the Securities Act of 1934 as to the timing, pricing, and volume of such transactions, and were funded from available cash resources, cash generated from the Company's operating activities, and draws from the Company's revolving line of credit with our syndicated commercial banking facility.

~~Table of Contents~~

Item 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

As used herein, the terms “Ebix,” “the Company,” “we,” “our” and “us” refer to Ebix, Inc., a Delaware corporation, and its consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only Ebix, Inc.

Safe Harbor for Forward-Looking Statements—This Form 10-Q and certain information incorporated herein by reference contains forward-looking statements and information within the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. This information includes assumptions made by, and information currently available to management, including statements regarding future economic performance and financial condition, liquidity and capital resources, acceptance of the Company’s products by the market, and management’s plans and objectives. In addition, certain statements included in this and our future filings with the Securities and Exchange Commission (“SEC”), in press releases, and in oral and written statements made by us or with our approval, which are not statements of historical fact, are forward-looking statements. Words such as “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “seeks,” “plan,” “project,” “continue,” “predict,” “will,” and other words or expressions of similar meaning are intended by the Company to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are found at various places throughout this report and in the documents incorporated herein by reference. These statements are based on our current expectations about future events or results and information that is currently available to us, involve assumptions, risks, and uncertainties, and speak only as of the date on which such statements are made.

Our actual results may differ materially from those expressed or implied in these forward-looking statements. Factors that may cause such a difference include, but are not limited to, those discussed ~~and identified in Part II, Item 1A "Risk Factors" in this quarterly report for the three months ended March 31, 2015 on this Form 10-Q, and~~ in Part I, Item 1A, “Risk Factors” in our ~~2014~~2015 Form 10-K which is incorporated by reference herein and identified, and in Part II, Item 1A "Risk Factors" for the three months ended March 31, 2016 in this Form 10-Q, as well as: ~~the risk of an unfavorable outcome of the pending governmental investigations, and the reputational harm caused by such investigations and lawsuits;~~ the willingness of independent insurance agencies to outsource their computer and other processing needs to third parties; pricing and other competitive pressures and the Company’s ability to gain or maintain share of sales as a result of actions by competitors and others; changes in estimates in critical accounting judgments; changes in or failure to comply with laws and regulations, including accounting standards, taxation requirements (including tax rate changes, new tax laws and revised tax interpretations) in domestic or foreign jurisdictions; exchange rate fluctuations and other risks associated with investments and operations in foreign countries (particularly in Australia, Latin America, and Europe wherein we have significant and/or growing operations); fluctuations in the equity markets, including market disruptions and significant interest rate fluctuations, which may impede our access to, or increase the cost of, external financing; and international conflict, including terrorist acts. The Company undertakes no obligation to update any such factors, or to publicly announce the results of, or changes to any of the forward-looking statements contained herein to reflect future events, developments, changed circumstances, or for any other reason.

Other important factors that could cause actual results to differ materially from those in our specific forward-looking statements included in this Form 10-Q include, but are not limited to, the following:

Regarding Note 4 of the Notes to the Condensed Consolidated Financial Statements, "Debt with Commercial Bank" and our future liquidity needs discussed under “Liquidity and Financial Condition” as pertaining to our ability to generate cash from operating activities and any declines in our credit ratings or financial condition which could restrict our access to the capital markets or materially increase our financing costs;

With respect to Note 5 of the Notes to the Condensed Consolidated Financial Statements, “Commitments and Contingencies”, and “Contractual Obligations and Commercial Commitments” in MD&A, as regarding ~~to changes in the market value of our assets or~~ the ultimate actual cost of our contractual commitments and contingencies;

With respect to Note 3 of the Condensed Notes to the Condensed Consolidated Financial Statements as pertaining to the business acquisitions we have made and our ability to efficiently and effectively integrate acquired business operations;

With respect to this Management Discussion & Analysis of Financial Condition and Results of Operation and the analysis of the three month revenue trends including the actual realized level of demand for our products during the immediately foreseeable future.

Readers should carefully review the disclosures and the risk factors described in this and other documents we file from time to time with the SEC, including future reports on Forms 10-Q and 8-K, and any amendments thereto. You may obtain our SEC filings at our website, www.ebix.com under the “Investor Information” section, or over the Internet at the SEC’s website, www.sec.gov.

~~Table of Contents~~

The following information should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in Part 1, Item 1 of this Quarterly Report, and the audited consolidated financial statements and

notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2014~~2015.

Company Overview

Ebix, Inc. is a ~~leading international~~global supplier of software and e-commerce solutions to the insurance, ~~industry.~~financial, and healthcare industries. Ebix provides a variety of application software products for the insurance industry ranging from carrier systems, agency systems and data exchanges to custom software development for all entities involved in insurance and financial services. Our goal is to be the leading provider of back-end insurance transaction processing in the world. The Company’s vision is to focus on the convergence of technology platforms for all insurance channels, processes and entities in a manner such that data seamlessly flows once a data entry has been made. Our customers include many of the top insurance ~~and financial~~ sector companies in the world.

The insurance industry ~~continues to undergo~~is undergoing significant consolidation driven by the need for, and benefits from, economies of scale and scope in providing insurance services in a competitive environment. Such consolidation has involved both insurance carriers and insurance brokers and is directly impacting the manner in which insurance products are distributed. Furthermore the insurance industry has particularly ~~experienced a steady~~continued to experience an increase in initiatives designed to reduce paper-based processes and to improve efficiency both at the back-end and consumer end sides. Management believes the insurance industry will continue to experience significant change and increased efficiencies through online exchanges, as the transition from paper-based processes are increasingly becoming the norm across world insurance markets. Changes in the insurance industry are ~~likely~~expected to create new opportunities for the Company.

Ebix strives to work collaboratively with clients to develop innovative technology strategies and solutions that address specific business challenges. Ebix combines the newest technologies with its capabilities in consulting, systems design and integration, IT and business process outsourcing, applications software, and Web and application hosting to meet the individual needs of insurance providers and related entities. We intend to continue to expand both organically and through strategic business acquisitions.

Offices and Geographic Information

The Company has its worldwide headquarters in ~~Atlanta,~~Johns Creek, Georgia with its international operations being managed from its Singapore offices, and it also has domestic operations in Santa Barbara, Pasadena, and Hemet, California; Miami, Florida; Pittsburgh, Pennsylvania; Salt Lake City, Utah; Grove City, Ohio; Bohemia, New York; Norwalk and New Britain, Connecticut; Portland, Michigan; Birmingham, Alabama; Iselin, New Jersey as well as an additional operations office in ~~Atlanta,~~Johns Creek, Georgia. The Company also has multiple operating facilities and offices in Australia, Brazil, Thailand, New Zealand, the United Kingdom, Canada, Singapore and India. In these operating offices, Ebix employs insurance and technology professionals who provide products, services, support and consultancy to thousands of customers across six continents.

Results of Operations — Three Months Ended March 31, ~~2015~~2016 and ~~2014~~2015

Operating Revenue

The Company derives its revenues primarily from subscription and transaction fees pertaining to services delivered over our exchanges or from our ASP platforms, fees for business process outsourcing services, and fees for software development projects including associated fees for consulting, implementation, training, and project management provided to customers with installed systems. International revenue accounted for ~~23.9%~~25.7% and ~~32.3%~~23.9% of the Company’s total revenue for the three months ended March 31, ~~2015~~2016 and ~~2014~~,2015, respectively.

Ebix’s revenue streams come from four product channels. Presented in the table below is the breakout of our revenues for each of those product channels for the three ~~months~~ month periods ended March 31, ~~2015~~2016 and ~~2014, respectively.~~2015.

~~Table of Contents~~


	Three Months Ended				Three Months Ended
	March 31,				March 31,
(dollar amounts in thousands)	2015		2014		2016		2015
Exchanges	$	46,678	$	42,105	$	50,086	$	46,678
Broker Systems	3,736		4,486		3,212		3,736
Risk Compliance Solutions (“RCS”)	12,175		3,425		16,751		12,175
Carrier Systems	1,164		1,388		1,017		1,164
Totals	$	63,753	$	51,404	$	71,066	$	63,753

During the three months ended March 31, ~~2015~~2016 our total operating revenues increased ~~$12.3~~$7.3 million or ~~24%~~11%, to ~~$63.8~~$71.1 million as compared to ~~$51.4~~$63.8 million during the first quarter of ~~2014. Revenues~~2015. The revenues increased primarily due to the recent signing of a number of new contracts such as ~~a result of revenue growth from Life, Annuity, Underwriting, CRM~~the recently signed PPL insurance underwriting exchange platform contract in London and ~~Health E-Commerce products~~the BSNL initiative in India, and ~~services,~~the acquisition PB Systems in ~~addition to revenue growth generated from the Company's 2014 acquisitions of HealthCare Magic, Vertex, and Oakstone, partially offset~~June 2015. Reported revenues were also effected by the ~~drop~~continuing weakening in ~~revenue from international locations due~~the foreign currencies in which we conduct operations (particularly in Australia, Brazil, Great Britain, and India) as compared to the strengthening of the U.S. ~~dollar and a decrease in revenues from~~dollar. Specifically, the ~~company’s pharmaceutical and P&C Carrier backend operations. The~~ adverse impact from fluctuations ofin the exchange rates for the foreign currencies in the countries in which we conduct operations ~~which~~ in the aggregate reduced reported revenues for the 1st quarter 2016 by ~~$1.9~~$1.8 million.

With respect to business acquisitions completed during the ~~years~~year 2015 ~~and 2014~~ on a pro forma basis, as disclosed in the table in Note 3 “Pro Forma Financial Information” to the enclosed Condensed Consolidated Financial Statements, combined revenues ~~decreased 2.0%~~increased $4.5 million or 6.8% for ~~the first quarter of 2015~~Q1 2016 versus the ~~first quarter of 2014~~Q1 2015 whereas correspondingly, the reported revenue for the three months ended March 31, ~~2015~~2016 increased by ~~$12.3~~$7.3 million or ~~24.0%~~11.5% from the reported revenue during the same period in ~~2014.~~2015. The ~~2015~~2016 and ~~2014~~2015 pro forma financial information assumes that all ~~such~~ business acquisitions made during this period were made on January 1, ~~2014,~~2015, whereas the Company's reported financial statements for Q1 ~~2015~~2016 and Q1 ~~2014~~2015 only includes the revenues from these businesses since the effective date that they were acquired by Ebix, being ~~January 2014 for CurePet, May 2014 for HealthCare Magic, October 2014 for Vertex, December 2014 for Oakstone and i3, and~~ March 2015 for Via Media ~~Health.~~Health and June 2015 for PB Systems. The ~~2014~~2015 pro forma financial information includes a full three months of results for ~~CurePet~~Via Media Health and ~~HealthCare Magic~~PB Systems as if they had been acquired on January 1, ~~2014.~~

2015.

The above referenced pro forma information and the relative comparative change in pro forma and reported revenues are based on the following premises:

~~2015~~2016 and ~~2014~~2015 pro forma revenue contains actual revenue of the acquired entities before acquisition date, as reported by the sellers, as well as actual revenue of the acquired entities after ~~acquisition. Whereas~~acquisition, whereas the reported growth in revenues of the acquired entities after acquisition date are only reflected for the period after their acquisition.

Revenue billed to existing clients from the cross selling of acquired products has been assigned to the acquired section of our business.

Any existing products sold to new customers obtained through a newly acquired customer base, are assigned to the acquired section of our business.

~~2014 pro forma revenues~~Pro formas do not include ~~revenues from some~~post acquisition revenue reductions as a result of discontinuation of any product lines ~~whose sales were discontinued after the acquisition date and revenues from some customers whose contracts were discontinued for efficiency~~ and/or ~~competitive reasons.~~customer projects by Ebix in its bid to maximize profitability.

Cost of Services Provided

Costs of services provided, which include costs associated with maintenance, customer support, call center, consulting, implementation and training services, increased ~~$9.9~~$117 thousand or 1%, to $19.6 million ~~or 103%,~~in the first quarter of 2016 as compared to $19.5 million in the first quarter of ~~2015 as compared to $9.61 million in the first quarter of 2014.~~2015. This increase is primarily due to greater ~~personnel, facility, and~~ external ~~consulting~~professional service costs associated with ~~the Q4'2014 acquisitions of~~our Oakstone ~~i3,~~medical education division and ~~Vertex.~~our Ebix Consulting division, and equipment costs associated with our recently formed Ebix Vayam Limited Joint Venture, partially offset by reductions in outside consulting costs and internal personnel costs.

Product Development Expenses

The Company’s product development efforts are focused on the development of new processing technologies, software, systems and related services for use by healthcare professions, consumers, insurance carriers, brokers and agents, and the development of new data exchanges for use in the domestic and international insurance markets. Product development expenses increased ~~$354 thousand~~$1.0 million or 5%14%, to $8.1 million during the first quarter of 2016 as compared to $7.0 million during the first quarter of ~~2015 as compared to $6.7 million during the first quarter of 2014.~~2015. This increase is attributable

~~Table of Contents~~

to additional personnel costs ~~and professional service expenses associated with increased software and system~~for our growing employee base in our product development ~~activities with the Q4 2014 acquisitions of Oakstone and i3.~~facilities in India.

Sales and Marketing Expenses

Sales and marketing expenses increased ~~$78~~$954 thousand or 2%28%, to ~~$3.38~~$4.33 million in the first quarter of ~~2015~~2016 as compared to ~~$3.30~~$3.38 million in the first quarter of ~~2014~~.2015. This increase is due to additional direct mail marketing and advertising costs in support of our continuing medical education services.

General and Administrative Expenses

General and administrative expenses increased by ~~$905 thousand~~$0.8 million or 9%8%, to $11.58 million in the first quarter of 2016 as compared to $10.75 million in the first quarter of ~~2015 as compared to $9.84 million in the first quarter of 2014.~~2015. This comparative year over year ~~net increase~~rise in general and administrative expenses is due to $1.1 million of increased personnel related costs (salaries, share-based compensation, and insurance benefits), $300 thousand of increased facilities costs, and $191 thousand of increased audit and legal costs. These cost increases were partially offset by a net reduction to general and administrative expenses in the amount of $511 thousand resulting from the remeasurements of and adjustments to the contingent earn out liabilities associated with ~~greater~~the acquisitions of Vertex (October 2014) and Via Media (March 2015), for which the liabilities were reduced by $720 thousand and $571 thousand respectively, and Qatarlyst (April 2013) for which the liability was increased by $780 thousand. The terms for the contingent earn out payments in most of the Company's business acquisitions typically address the GAAP recognizable revenues achieved by the acquired entity over a one, two, and/or three year period subsequent to the effective date of their acquisition by Ebix. These terms typically establish a minimum threshold revenue target with achievement of revenues recognized over that target being awarded in the form of a specified earn out payment. The Company applies these terms in its calculation and determination of the fair value of contingent earn out liabilities for purchased businesses as part of the related valuation and purchase price allocation exercise for the corresponding acquired assets and liabilities. During the 1st quarter of 2016 the cited contingent earn out liabilities were adjusted because of changes to anticipated future revenues from these acquired businesses. The cause for the Vertex and Via Media contingent liability reductions is due the fact that the acquired businesses earn out revenue targets were based on revenue run rates at the time of the acquisitions, their growth trajectories, and their client contracts in hand at the time the businesses were acquired, while in recent times their revenues have been impacted downwards by certain unforeseen changes in terms of the pace of project implementation and resource budget allocation by some of their key clients. The cause for the Qatarlyst contingent liability increase is due to recent signing of the PPL insurance ~~costs~~underwriting exchange platform contract in London, and ~~bank fees.~~the assured revenue stream to be forthcoming from this arrangement.

Amortization and Depreciation Expenses

Amortization and depreciation expenses ~~remained essentially flat at $2.6~~increased $123 thousand or 5% to $2.72 million in the first quarter of 2016 as compared to $2.60 million in the first quarter of 2015, ~~as compared~~due to ~~$2.6 million in the first quarter of 2014, increasing only $46 thousand or 2%. $1.84 million of this~~additional depreciation expense ~~pertains to the amortization of intangible assets acquired~~ in connection with ~~previous business combinations~~the build out and ~~$761 thousand pertains~~purchase of newly acquired equipment with respect to ~~depreciation expense associated with equipment used~~our new corporate headquarters office and campus facilities in Johns Creek, Georgia, and our ~~operating activities.~~expanding product development facilities in India.

Interest Income

Interest income ~~decreased $74~~increased 134% to $143 thousand ~~or 55%,~~in the first quarter of 2016 as compared to $61 thousand in the first quarter of 2015, ~~as compared~~due to ~~$135 thousand in the first quarter of 2014. Interest income decreased as~~ a ~~result of the year over year decrease~~58% increase in average ~~interested bearing~~ cash balances ~~which decreased 31% to $39.8 million~~held during Q1 of ~~2015 from $57.2 million during~~2016 versus Q1 of ~~2014.~~2015 which increased to $63.1 millions from $39.8 million.

Interest Expense

Interest expense increased ~~$472~~$555 thousand or ~~191%~~77%, to $1.3 million in the first quarter of 2016 as compared to $719 thousand in the first quarter of ~~2015 as compared to $247 thousand in the first quarter of 2014.~~2015. Interest expense increased due to the increase in the average outstanding balance on our commercial banking credit facilities, which increased ~~143%~~65% to $209.8 million during Q1 2016 from $127.4 million during ~~Q1 of 2015 from $52.4 million during Q1 of 2014.~~the same period in 2015.

Foreign Currency Exchange Gain

Net foreign currency exchange gains for the three months ended March 31, ~~2015~~2016 in the amount of ~~$892~~$469 thousand ~~and~~ consists of ~~$433~~$444 thousand of gains realized upon the settlement of ~~transactions~~receivables or payables denominated in currencies other than the functional currency of the respective operating division ~~recognizing~~recording the ~~transaction,~~instrument and ~~$459~~$25 thousand of unrealized gains recognized upon the remeasurement of certain other outstanding receivables or payables denominated in currencies other than the functional currency of the respective operating division recording the instrument.

Income Taxes

The Company's consolidated world-wide effective tax rate reflects the tax benefits of conducting operating activities in certain foreign jurisdictions where earnings are taxed at rates lower than U.S. statutory rates and where certain components of the Company's income are exempt from taxation. Furthermore, the Company's product development operations and intellectual property ownership have been centralized into our India and Singapore subsidiaries. Our operations in India benefit from a tax holiday, which affects various operating facilities in that country. The tax holiday expired for one of our facilities in April of 2014 for two other of our facilities in April 2015, and will expire for the remaining of our other facilities in India in the years 2016 through 2018. As such a significant component of the income generated by our India operations, other than passive interest income, is not taxed. After the expiration of the full tax holidays the income is taxed at 50% of the normal 33.99% corporate tax rate for a period of five years. The Company also has a relatively low income tax rate in Singapore wherein our operations are taxed at a 10% tax rate as a result of concessions granted by the local Singapore Economic Development Board for the benefit of in-country intellectual property owners. The concessionary 10% income tax rate will expire in Q2 2015, at which time our Singapore operations will be subject to the prevailing corporate tax rate in Singapore, which is currently 17%, unless the Company reaches a subsequent agreement to extend the incentive period and the then applicable concessionary rate or possibly secure a lower concessionary tax rate. The Company believes the concessionary rate will be extended.

~~The Company recognized total~~recorded income tax expense of $1.7 million (7.3%) and $2.4 million ~~for~~(11.6%) during the three months ended March 31, 2016 and 2015, ~~as compared~~respectively. Our tax expense and effective tax rate decreased year over year, exclusive of discrete charges, due to ~~$4.2 million for~~favorable changes in the ~~three months~~proportion of our taxable income in certain low tax rate foreign jurisdictions relative to total pre-tax income. The Company expects its full year effective tax rate to be approximately 7.7%.

The Company’s effective tax rate reflects the benefits of having significant operations outside the United States, which are generally taxes at rates lower than the US statutory rate of 35% and also due to the fact that the Company enjoys a tax holiday in India. During 2015, the Company secured an additional tax holiday in India until the year 2020 to support certain portions of its expanding operations in that country. The Company also had income during the quarter ended March 31, ~~2014. The Company's interim period income~~2016 in Singapore, the United Kingdom and Sweden, where the statutory tax ~~provisions~~rates are ~~based on a~~

~~Table of Contents~~

~~calculated estimate of~~lower than the effective income tax rate expected to be applicable to the corresponding annual period, after eliminating discrete items unique to the respective interim period being reported. The Company's interim period tax provision for the three month period ending March 31, 2015 reflects an effective taxUS rate of 11.43%, as compared to the 12.01% also exclusive of discrete items, for the same period in 2014. The effective rate decreased slightly due to less taxable income from jurisdictions with higher tax rates.35%.

Liquidity and Capital Resources

The Company's ability to generate significant cash flows from ~~its~~ ongoing operating activities is one of our fundamental financial strengths. Our principal sources of liquidity are the cash flows provided by the Company's operating activities, our commercial banking credit facility, and cash and cash equivalents on hand. Due to the effect of temporary or timing differences resulting from the differing treatment of items for tax and accounting purposes (including the treatment of net operating loss carryforwards and minimum alternative tax obligations in the U.S. and Great Britain, and India, respectively), future cash outlays for income taxes are expected to exceed income tax expense. We intend to utilize cash flows generated by our operations, in combination with our commercial bank credit facility, and the possible issuance of additional equity or debt securities, to fund capital expenditures and organic growth initiatives, ~~and~~ to make strategic and accretive business acquisitions in the insurance services ~~sector.~~sector, and to re-purchase shares of our common stock as market conditions warrant.

We believe that anticipated cash flows provided by our operating activities, together with current cash and cash equivalent balances, access to our credit facilities, and access to the capital markets, if required and available, will be sufficient to meet our projected cash requirements for the foreseeable future, although any projections of future cash needs, cash flows, and the condition of the capital markets in general, as to the availability of debt and equity financing, are subject to substantial uncertainty.

Our cash and cash equivalents were ~~$27.2~~$69.0 million and ~~$52.3~~$57.2 million at March 31, ~~2015~~2016 and December 31, ~~2014~~,2015, respectively. The free flow of cash from certain countries where we hold significant cash balances may be subject to repatriation tax effects and other restrictions. Specifically the repatriation of earnings from some of our foreign subsidiaries could result in the application of withholding taxes at that foreign source as well as a tax at the U.S. parent level upon receipt of repatriated amounts. The approximate cash, cash equivalents, and short-term investments balances held in our domestic U.S. operations and each of our foreign subsidiaries as of May ~~8, 2015~~6, 2016 are presented in the table below (figures denominated in thousands):

United States Canada Latin America Australia Singapore New Zealand India Europe Sweden Total
Cash and ST investments $ 6,681
$ 1,667
$ 839
$ 4,416
$ 3,460
$ 1,527
$ 5,867
$ 1,577
$ 13
$ 26,047



	United States		Canada		Latin America		Australia		Singapore		New Zealand		India		Europe		Sweden		Total
Cash and ST investments	$	17,901	$	1,576	$	1,779	$	7,753	$	18,911	$	3,010	$	18,559	$	1,862	$	13	$	71,364

Our current ratio increased ~~moderately~~ to ~~1.74~~3.15 at March 31, ~~2015~~2016 from ~~1.49~~2.28 at December 31, ~~2014~~2015 and our working capital position accordingly has also increased ~~slightly~~ to ~~$35.2~~$95.0 million at March 31, ~~2015~~2016 from ~~$34.1~~$65.6 million at the end of 2015. Our short-term liquidity has improved due to increased cash and cash equivalent balances on hand, and increased outstanding trade accounts receivables combined with a reduction in accounts payable and accrued liabilities. The Company's accounts receivable DSO was 72 days at March 31, 2016 up from 62 days at December 31, 2015. This DSO increase is expected to be temporary as accounts receivable collections have significantly improved during the ~~2014.~~ early part of Q2 2016.

We believe that Ebix's ability to generate sustainable and robust cash flows from operations will enable the Company to continue to fund its current liabilities from current assets including available cash balances for the foreseeable future.

Business Combinations

The Company seeks to execute accretive business acquisitions in combination with organic growth initiatives as part of its comprehensive business growth and expansion strategy. The Company looks to acquire businesses that are complementary to Ebix's existing products and services.

During the three months ended March 31, 2016 the Company did not have any business acquisitions.

During the year ended December 31, 2015, the Company completed ~~one~~two business acquisitions, as follows:

The Company acquired PB Systems, Inc. and PB Systems Private Limited (together being "PB Systems"), effective June 1, 2015. PB Systems develops and implements software solutions for insurance clients. Ebix acquired PB Systems for upfront cash consideration in the amount of $12.4 million, plus a possible future one-time contingent earnout payment of up to $8.0 million based on earned revenues and the reported EBITDA margins over the subsequent twenty-four month period following the effective date of the acquisition. The Company has determined that the fair value of the contingent earn out consideration is $990 thousand as of March 31, 2016. The valuation and purchase price allocation for the PB Systems acquisition remains preliminary.

Effective December 2, 2014, Ebix acquired Oakstone Publishing, LLC ("Oakstone") in a membership interest purchase agreement for total net cash consideration in the amount of $23.72 million ($31.37 million less a closing net working capital adjustment of $7.65 million). Oakstone is leading provider of continuing education, certification materials for physicians, dentists and allied healthcare professionals, as well as wellness resources for various organizations. Ebix acquired all of the outstanding membership interests of Oakstone and funded the purchase using a mix of internal cash reserves and the bank credit line available to Ebix. The Company ~~accounted for this acquisition by recording $28.8 million of goodwill, $1.7 million of intangible assets~~

~~Table of Contents~~

pertaining to customer relationships, $501 thousand of intangible assets pertaining to acquired technology, and a $6.5 million deferred revenue liability. The valuation and purchase price allocation forhas determined that the ~~Oakstone acquisition remains preliminary and will be finalized prior to June 30, 2015.~~

A significant component of the purchase price consideration for many of the Company's business acquisitions is a potential subsequent cash earnout based on reaching certain specified future revenue targets. The terms for the contingent earn out payments in most of the Company's business acquisitions typically address the GAAP recognizable revenues achieved by the acquired entity over a one, two, and/or three year period subsequent to the effective date of their acquisition by Ebix. These terms typically establish a minimum threshold revenue target with achievement of revenues recognized over that target being awarded in the form of a specified earn out payment. The Company applies these terms in its calculation and determination of the fair value of contingent earn out liabilities for purchased businesses as part of the related valuation and purchase price allocation exercise for the corresponding acquired assets and liabilities. The Company recognizes these potential obligations as contingent liabilities. These contingent consideration liabilities are recorded at fair value on the acquisition date and are re-measured quarterly based on the then assessed fair value and adjusted if necessary. As of March 31, ~~2015~~,2016, the total of these contingent liabilities was ~~$5.33~~$3.74 million,, of which ~~$4.44~~$1.60 million is reported in long-term liabilities, and ~~$887 thousand~~ is$2.14 million was included in current liabilities in the Company's Condensed Consolidated Balance Sheet. As of December 31, ~~2014~~2015 the total of these contingent liabilities was ~~$5.4~~$4.28 million, of which ~~$4.5~~$2.57 million is reported in long-term liabilities, and ~~$887 thousand is~~$1.71 million was included in current liabilities in the Company's Condensed Consolidated Balance Sheet. During the 1st quarter of 2016 the cited contingent earn out liabilities were adjusted because of changes to anticipated future revenues from these acquired businesses.

Operating Activities

Net cash provided by our operating activities was $10.5 million for the three months ended March 31, 2016. The primary components of the cash used in operations during the three month period consisted of net income of $22.2 million, net of $(48) thousand of unrealized foreign currency exchange gains, $2.7 million of depreciation and amortization, $192 thousand of net income attributable to a noncontrolling interest, $647 thousand of non-cash share-based compensation, and $326 thousand of amortization of capitalized software development costs. Partially offsetting this net cash inflow was $(15.0) million of working capital requirements primarily associated with increased outstanding trade accounts receivable combined with a reduction in accounts payable and accrued expenses. During the three months ended March 31, 2016 the Company made $7.0 million of tax payments including $6.0 million of minimum alternative tax payments in India, which is a component of net deferred tax assets on the Company's Condensed Consolidated Balance Sheets.

Net cash used by our operating activities was $(7.3) million for the three months ended March 31, 2015. The primary components of the cash used in operations during the three months period consisted of $(27.4) million of working capital requirements primarily associated with increased outstanding trade accounts receivable and the cash payment of the $20.5 million assessment (including interest of $1.6 million) stemming from the resolution of the Internal Revenue Service's previously disclosed audit of Ebix’s income tax returns for the taxable years 2008 through 2012. Partially offsetting these cash outflows was net income

~~Table of Contents~~

of $18.3 million, net of $(672) thousand of unrealized foreign currency exchange gains, $2.6 million of depreciation and amortization, and $0.5 million of non-cash share-based compensation.

Investing Activities

Net cash ~~provided by our operating~~used for investing activities ~~was $10.8 million for~~during the three months ended March 31, ~~2014. The primary components of the cash provided by operations during the three months period consisted of net income of $15.4 million, net of $(0.2)~~2016 was $1.8 million, of ~~net non-cash gains recognized on derivative instruments~~which $1.0 million was used for the continued build out of our global corporate headquarters campus in Johns Creek, Georgia and foreign currency exchange, $2.6 million of depreciation and amortization, $(1.8) million of non-cash gains associated with the reduction to acquisition related earnout contingent liabilities, $(1.4) million of working capital requirements primarily associated with increased outstanding trade accounts receivable and reduced trade payables, and a $(4.2) million payment in satisfaction of the then outstanding securities litigation settlement obligation, and $0.4 million of non-cash share-based compensation.our

~~Investing Activities~~expanding product development facilities in India, and $596 thousand was used for the purchase of marketable securities (specifically bank certificates of deposit).

Net cash used for investing activities during the three months ended March 31, 2015 was $6.8 million, of which $5.4 million was used for the continued interior build out of our new new global corporate headquarters campus in ~~the Atlanta metropolitan area,~~Johns Creek, Georgia, $1.0 million was used for the acquisition of Via Media Health, and $351 thousand of capital expenditures pertaining to the enhancement of our technology platforms and the purchases of operating equipment to support our expanding operations.

~~Net cash used for investing activities during~~Financing Activities

During the three months ended March 31, ~~2014~~2016 net cash provided by financing activities was ~~$0.4~~$2.8 million which ~~primarily~~ consisted of ~~capital expenditures.~~$20.0 million provided by draws off the Company's revolving credit facility offset by $14.8 million used to repurchase 466 thousand shares of our common stock and $2.4 million used to pay quarterly dividends to our common stockholders.

~~Financing Activities~~

During the three months ended March 31, 2015 net cash used by financing activities was $10.0 million which consisted of $22.3 million was used to repurchase shares of our common stock, $2.7 million was used to pay a quarterly dividend to our common stockholders, ~~$22.3 million was used to repurchase shares of our common stock,~~ and $12 thousand was used to make principal payments on long-term debt and capital lease obligations. Partially offsetting these financing cash outflows was $15.0 million provided by the Company's revolving credit facility with Regions.

During the three months ended March 31, 2014 net cash used by financing activities was $10.0 million which primarily consisted of $2.4 million of principal repayments against the term loan facility with Citibank, $2.9 million used to pay a quarterly dividend to our common stockholders, $2.2 million used to repurchase shares of our common stock, $3.2 million of excess tax benefits associated with share-based compensation, and $65 thousand used to make principal payments on long-term debt and capital lease obligations. Partially offsetting these financing cash outflows was $788 thousand of proceeds from the exercise of stock options.

Commercial Bank Financing Facility

On October 14, 2015 Ebix exercised the $50 million accordion feature under the Regions Secured Credit Facility (as defined below). TD Bank, NA was added to the syndication group along with four other bank participants which includes Regions. The exercise of the accordion feature increased the Aggregate Revolving Commitment under the Credit Agreement to $240 million from the prior amount of $190 million.

On February 3, 2015 ~~the Company and certain of its subsidiaries~~Ebix entered into the First Amendment to the Regions Secured Credit Facility, dated August 5, 2014, among the Company, Regions as Administrative Agent, with Regions, MUFG Union Bank N.A., and Silicon Valley Bank as joint lenders. The First Amendment ~~amends~~amended the Credit Agreement by increasing the maximum amount by which the Aggregate Revolving Commitments may be increased to $90 million from the pre-existing limit of $50 million, ~~increases~~increased the amount of base facility to $190 million from the pre-existing amount of $150 million, which together with the $50 million accordion feature ~~increases~~increased the total Credit Agreement capacity amount to $240 million from the prior amount of $200 million, and ~~expands~~expanded the syndicated bank group to four participants by adding Fifth Third Bank.

On August 5, 2014, Ebix entered into a credit agreement providing for a $150 million secured syndicated credit facility (the “Regions Secured Credit Facility”) with Regions as administrative agent and Regions with MUFG Union Bank N.A., and Silicon Valley Bank as joint lenders. The financing iswas comprised of a five-year, $150 million secured revolving credit facility, with an option to expand to $200 million upon request and with additional lender participation. This new $150 million credit facility with Regions, as administrative agent, ~~replaces~~replaced the former syndicated $100 million facility that the Company had in place with Citi Bank, N.A. which was paid in full upon the undertaking of this new loan facility with Regions. The interest rate applicable to the Regions Secured Credit Facility is LIBOR plus 1.5% ~~or currently 1.69%~~. Under the Regions Secured Credit Facility the maximum interest rate that could be charged depending upon the Company's leverage ratio is LIBOR plus 2.25%. The underlying financing agreement contains financial covenants regarding the Company's annualized fixed charge coverage ratio and leverage ratio, as well as certain restrictive covenants pertaining to such matters as the incurrence of new debt and the consummation of new business acquisitions. The Company currently is in compliance with all such financial and restrictive covenants. As of March 31, 2016 the Company's consolidated balance sheet includes $1.5 million of remaining deferred financing costs related to this credit facility.

~~Table of Contents~~

At March 31, ~~2015,~~2016, the outstanding balance on the revolving line of credit under the Regions Secured Syndicated Credit Facility was ~~$135.5~~$226.5 million and the facility carried an interest rate of ~~1.69%~~2.50%. During the three months ended March 31, ~~2015,~~2016, $20.0 million of draws were made off of the revolving credit facility, and no payments were made against the revolving line of credit. The revolving line of credit balance is included in the long-term liabilities section of the Condensed Consolidated Balance Sheets. During the three months period ended March 31, ~~2015,~~2016, the average and maximum outstanding balances on our revolving line of credit facilities were ~~$127.4~~$209.8 million and ~~$135.5~~$226.5 million, respectively.

Off-Balance Sheet Arrangements

We do not engage in off -balance sheet financing arrangements.

Recent Accounting Pronouncements

For information about new accounting pronouncements and the potential impact on our Consolidated Financial Statements, see Note 1 of the condensed notes to the Condensed Consolidated Financial Statements in this Form 10-Q and Note 1 of the notes to consolidated financial statements in our ~~2014~~2015 Form 10-K.

Application of Critical Accounting Policies

The preparation of financial statements in conformity with Generally Accepted Accounting Principles (“GAAP”), as promulgated in the United States, requires our management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and related disclosures in our Condensed Consolidated Financial Statements and accompanying notes. We believe the most complex and sensitive judgments, because of their significance to the Condensed Consolidated Financial Statements, result primarily from the need to make estimates and assumptions about the effects of matters that are inherently uncertain. The following accounting policies involve the use of “critical accounting estimates” because they are particularly dependent on estimates and assumptions made by management about matters that are uncertain at the time the accounting estimates are made. In addition, while we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have ~~possibly~~ been used in the current period, and changes in the accounting estimates that we used are reasonably likely to occur from period to period both of which may have a material impact on our financial condition and results of operations. For additional information about these policies, see Note 1 of the Condensed Notes to the Condensed Consolidated Financial Statements in this Form 10-Q. Although we believe that our estimates, assumptions and judgments are reasonable, they are limited based upon information presently available. Actual results may differ significantly from these estimates under different assumptions, judgments or conditions.

Revenue Recognition

In accordance with the Financial Accounting Standards Board ("FASB") and SEC accounting guidance on revenue recognition the Company considers revenue earned and realizable when: (a) persuasive evidence of the sales arrangement exists, provided that the arrangement fee is fixed or determinable, (b) delivery or performance has occurred, (c) customer acceptance has been received, if contractually required, and (d) collectability of the arrangement fee is probable. The Company uses signed contractual agreements as persuasive evidence of a sales arrangement. We apply the provisions of the relevant generally accepted accounting principles related to all transactions involving the license of software where the software deliverables are considered more than inconsequential to the other elements in the arrangement.

For contracts that contain multiple deliverables, we analyze the revenue arrangements in accordance with the relevant technical accounting guidance, which provides criteria governing how to determine whether goods or services that are delivered separately in a bundled sales arrangement should be considered as separate units of accounting for the purpose of revenue recognition. Generally these types of arrangements include deliverables pertaining to software licenses, system set-up, and professional services associated with product customization or modification. Delivery of the various contractual elements typically occurs over periods of less than eighteen months. These arrangements generally do not have refund provisions or have very limited refund terms.

~~Table of Contents~~

Allowance for Doubtful Accounts Receivable

Management specifically analyzes accounts receivable and historical bad debts, write-offs, customer concentrations, customer credit-worthiness, current economic trends and changes in our customer payment terms when evaluating the adequacy of the allowance for doubtful accounts.

Valuation of Goodwill and Other Indefinite-Lived Intangible Assets

Goodwill represents the cost in excess of the fair value of the net assets of acquired businesses. Indefinite-lived intangible assets represent the fair value of acquired contractual customer relationships for which future cash flows are expected to continue

indefinitely. In accordance with the relevant FASB accounting guidance, goodwill and indefinite-lived intangible assets are not amortized but are tested for impairment at the reporting unit level on an annual basis or on an interim basis if an event occurs or circumstances change that would likely have reduced the fair value of a reporting unit below its carrying value. Potential impairment indicators include a significant change in the business climate, legal factors, operating performance indicators, competition, and the sale or disposition of a significant portion of the business. The impairment evaluation process first involves an assessment of certain qualitative factors to determine whether the existence of events or circumstances would indicate that it is more likely than not that the fair value of any of our reporting units was less than its carrying amount. If, after assessing the totality of events or circumstances, we were to determine that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then we would not perform the two-step quantitative impairment testing described further below.

The aforementioned two-step quantitative testing process involves comparing the reporting unit carrying values to their respective fair values. We determine the fair value of our reporting units by applying the discounted cash flow method using the present value of future estimated net cash flows. If the fair value of a reporting unit exceeds its carrying value, then no further testing is required. However, if a reporting unit's fair value were to be less than its carrying value, we would then determine the amount of the impairment charge, if any, which would be the amount that the carrying value of the reporting unit's goodwill exceeded its implied value. Projections of cash flows are based on our views of growth rates, operating costs, anticipated future economic conditions and the appropriate discount rates relative to risk and estimates of residual values. We believe that our estimates are consistent with assumptions that marketplace participants would use in their estimates of fair value. The use of different estimates or assumptions for our projected discounted cash flows (e.g., growth rates, future economic conditions, discount rates and estimates of terminal values) when determining the fair value of our reporting units could result in different values and may result in a goodwill impairment charge. We perform our annual goodwill impairment evaluation and testing as of September 30th of each year. This evaluation is done during the fourth quarter each year. During the year ended December 31, ~~2014~~2015 we had no impairment of our reporting unit goodwill balances.

Valuation of Contingent Liabilities related to Earn Out Obligations from Business Acquisitions

A significant component of the purchase price consideration for many of the Company's business acquisitions is a potential subsequent cash earnout payment based on reaching certain specified future revenue targets. The Company recognizes these potential obligations as contingent liabilities and are reported accordingly on its Condensed Consolidated Balance Sheets. As discussed in more detail in Note 1 to the accompanying Condensed Consolidated interim financial statements, these contingent consideration liabilities are recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary.

Income Taxes

Deferred income taxes are recorded to reflect the estimated future tax effects of differences between financial statement and tax basis of assets, liabilities, operating losses, and tax credit carry forwards using the tax rates expected to be in effect when the temporary differences reverse. Valuation allowances, if any, are recorded to reduce deferred tax assets to the amount management considers more likely than not to be realized. Such valuation allowances are recorded for the portion of the deferred tax assets that are not expected to be realized based on the levels of historical taxable income and projections for future taxable income over the periods in which the temporary differences will be deductible.

Foreign Currency Matters

The functional currency for the Company's foreign subsidiaries in India and Singapore is the U.S. dollar because the intellectual property research and development activities provided by its Singapore subsidiary, and the product development and information technology enabled services activities for the insurance industry provided by its India subsidiary. both in support of Ebix's operating divisions across the world, are transacted in U.S. dollars.

The functional currency of the Company's other foreign subsidiaries is the local currency of the country in which the subsidiary operates. The assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at the rates of exchange at the balance sheet dates. Income and expense accounts are translated at the average exchange rates in effect during the period. Gains and losses resulting from translation adjustments are included as a component of other comprehensive income in the accompanying Condensed Consolidated Balance Sheets. Foreign exchange transaction gains and losses that are derived from transactions denominated in a currency other than the subsidiary's functional currency are included in the determination of net income.

~~Table of Contents~~

Item 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company is exposed to foreign currency exchange rate risk related to our foreign-based operations where certain transactions are denominated in other than our entity's functional currency and are subject to market risk with respect to fluctuations in the relative value of those currencies. Most of the Company's transactions are denominated in U.S. dollars, however, the Company has significant and expanding operations in Australia, Brazil and Europe, and we conduct transactions in the local currencies of each of those locations. There can be no assurance that fluctuations in the value of foreign currencies will not have a material adverse effect on the Company’s business, operating results, revenues or financial condition. During the three months ended March 31, ~~2015~~2016 and ~~2014~~2015 the net change in the cumulative foreign currency translation account, which is a component of accumulated other comprehensive loss within stockholders’ equity, were unrealized ~~gains (losses)~~losses of ~~$(5.4)~~$1.7 million and ~~$1.1~~$5.4 million, respectively. The Company considered the historical trends in currency exchange rates and determined that it was reasonably possible that adverse changes in our respective foreign currency exchange rates of 20% could be experienced in the near term. Such an adverse change in currency exchange rates would have resulted in reduction to pre-tax income of approximately $940 thousand and $720 thousand ~~and $1.0 million~~ for the three months ended March 31, ~~2015~~2016 and ~~2014~~,2015, respectively.

The Company's exposure to interest rate risk relates to its interest expense on outstanding debt obligations and to its interest income on existing cash balances. As of March 31, ~~2015~~2016 the Company had ~~$136.7~~$227.1 million of outstanding debt obligations which consisted of a ~~$135.47~~$226.47 million balance on our commercial banking revolving line of credit, and a ~~$1.23 million~~$600 thousand in secured promissory note payable. The Company's revolving line of credit bears interest at the rate of LIBOR plus 1.50%, and stood at ~~1.69%~~2.50% at March 31, ~~2015.~~2016. The Company is exposed to market risk in relation to this line of credit in regards to the potential increase in interest expense arising from adverse changes in interest rates. This interest rate risk is estimated as the potential decrease in earnings resulting from a hypothetical 30% increase in the LIBOR rate. Such an adverse change in the LIBOR rate would have resulted in a reduction to pre-tax income of approximately ~~$20~~$107 thousand and $6$20 thousand for the three months ended March 31, ~~2015~~2016 and ~~2014,~~2015, respectively. The Company's average cash balances during the three months ended March 31, ~~2015~~2016 were ~~$39.8~~$63.1 million and its existing cash balances as of March 31, ~~2015~~2016 were ~~$27.2~~$69.0 million. The Company is exposed to market risk in relation to these cash balances in regards to the potential loss of interest income arising from adverse changes in interest rates. This interest rate risk is estimated as the potential decrease in earnings resulting from a hypothetical 20% decrease in interest rates earned on deposited funds. Such an adverse change in these interest rates would have resulted in a reduction to pre-tax income of approximately ~~$12~~$29 thousand and ~~$27~~$12 thousand for the three months ended March 31, ~~2015~~2016 and ~~2014,~~2015, respectively.

There were no other material changes to our market risk exposure during the three months ended March 31, ~~2015~~2016 and ~~2014~~2015. For additional information regarding our exposure to certain market risks, see “Quantitative and Qualitative Disclosures about Market Risk,” in Part II, Item 7A of our ~~2014~~2015 Form 10-K.

~~Table of Contents~~

Item 4: CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures: The Company's management evaluated, with the participation of the Chief Executive Officer and Chief Financial Officer, the effectiveness of the Company's disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures were effective as of the end of the period covered by this report.

Internal Control over Financial Reporting: There were no changes in our internal control over financial reporting during the three months ended March 31, ~~2015~~2016, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Part II — OTHER INFORMATION

Item 1: LEGAL PROCEEDINGS

On December 3, 2012, the Company received a subpoena and letter from the ~~SEC~~Securities and Exchange Commission (“SEC”) dated November 30, 2012, stating that the SEC is conducting a formal, non-public investigation styled In the Matter of Ebix, Inc. (A-3318) and seeking documents primarily related to the issues raised in the In re: Ebix, Inc. Securities Litigation. On April 16, 2013, the Company received a second subpoena from the SEC seeking additional documents. The Company has cooperated with the SEC to provide the requested documents.

Following ~~our~~the announcement on May 1, 2013 of the Company's execution of a merger agreement with affiliates of

Item 1A: RISK FACTORS

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2014,~~2015, which could materially affect the Company's business, financial condition or future results. There have not been any significant changes with respect to the risk factors described in Ebix's ~~2014 Annul~~2015 Annual Report on Form 10-K. The risks described in that ~~2014~~2015 Form 10-K and in this Quarterly Report on Form 10-Q are not the only risks that the Company faces. Additional risks and

~~Table of Contents~~

uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

~~Table of Contents~~

Item 2: REPURCHASES OF EQUITY SECURITIES

The following table contains information with respect to purchases of our common stock made by or on behalf of Ebix during the three months ended March 31, ~~2015~~,2016, as part of our publicly-announced share repurchase plan:

Total Number of Shares (Units) Purchased Total Number of Shares Purchased as Part of
Publicly-Announced Plans or Programs Average Price Paid Per Share (1) Maximum Number (or
Approximate Dollar Value) of
Shares that May Yet Be
Purchased Under the Plans or Programs (2) (3)
Period

As of December 31, 2014 7,853,514
7,853,514
$ —
$ 71,033,000
January 1, 2015 to January 31, 2015 292,179
292,179
$ 22.40
$ 64,488,000
February 1, 2015 to February 28, 2015 475,358
475,358
$ 24.47
$ 52,857,000
March 1, 2015 to March 31, 2015 (4)

227,332
227,332
$ 26.61
$ 46,809,000
Total 8,848,383
8,848,383
$ 46,809,000



	Total Number of Shares (Units) Purchased	Total Number of Shares Purchased as Part of Publicly-Announced Plans or Programs	Average Price Paid Per Share (1)		Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs (2) (3)
Period	Total Number of Shares (Units) Purchased		Average Price Paid Per Share (1)

As of December 31, 2015 (3)	10,777,820	10,777,820	$	—	$	88,558,000
January 1, 2016 to January 31, 2016	377,037	377,037	$	29.67	$	77,371,000
February 1, 2016 to February 29, 2016	88,523	88,523	$	31.41	$	74,590,000
March 1, 2016 to March 31, 2016	—	—	$	—	$	74,590,000
Total	11,243,380	11,243,380			$	74,590,000


(1)	Average price paid per share for shares purchased as part of our publicly-announced plan.

(2)

Effective June 30, 2011 the Company's Board of Directors unanimously approved an increase in the size of the Company's authorized share repurchase plan from $45.0 million to $100.0 million. The Board directed that the repurchases be funded with available cash balances and cash generated by the Company's operating activities, and be completed in the subsequent twelve months if possible. As of March 31,August 19, 2015 there are no remaining share repurchase authorizations for this plan. Under certain circumstances the aggregate amount of repurchases of the Company's equity shares may be limited by the terms and underlying financial covenants regarding the Company's commercial bank financing facility.

~~(3)~~

~~Effective June 21, 2013~~ the Company's Board of Directors unanimously approved an additional authorized share repurchase plan of $100.0 million. The Board directed that the repurchases be funded with available cash balances and cash generated by the Company's operating ~~activities, and be completed in the subsequent twenty four months if possible.~~activities. Under certain circumstances the aggregate amount of repurchases of the Company's equity shares may be limited by the terms and underlying financial covenants regarding the Company's commercial bank financing facility.


~~(4)~~(3)	As of ~~March~~December 31, 2015 there were ~~64,893~~25,000 shares totaling ~~$1.94 million~~$820 thousand of share repurchases that were not settled until ~~April 2015.~~January 2016.

Item 3: DEFAULTS UPON SENIOR SECURITIES

None.

Item 4: MINE SAFETY DISCLOSURES

Not applicable.

Item 5: Other Information.

None.

Item 6: EXHIBITS

The exhibits filed herewith or incorporated by reference herein are listed in the Exhibit Index attached hereto.

~~Table of Contents~~

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.




		Ebix, Inc.
Date:	May ~~11, 2015~~10, 2016	By:	/s/ Robin Raina
			Robin Raina
			Chief Executive Officer (Principal Executive Officer)

Date:	May ~~11, 2015~~10, 2016	By:	/s/ Robert F. Kerris
			Robert F. Kerris
			Chief Financial Officer (Principal Financial and Accounting Officer)

~~Table of Contents~~

EXHIBIT INDEX



Exhibits
3.1		Certificate of Incorporation, as amended, of Ebix, Inc. (filed as Exhibit 3.1 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and incorporated herein by reference).
~~3.2~~		~~Bylaws of the Company (filed as Exhibit 3.2 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2000 and incorporated herein by reference).~~
3.3		Amended and Restated Bylaws of Ebix, Inc., effective immediately following the Company’s Annual Meeting of Stockholders, held on January 9, 2015 (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K dated December 24, 2014).
~~10.1~~		Amendment No.1 and Waiver dated February 3, 2015 to the Credit Agreement dated as of August 5, 2014, entered into by and among Ebix, Inc., as Borrower, certain subsidiaries of the Company from time to time party thereto, as Guarantors, Regions Bank, as Administrative Agent and Collateral Agent, and the lenders from time to time party thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated February 5, 2015).
~~10.2~~		Amendment dated as of March 23, 2015 to the Director Nomination Agreement, dated as of November 26, 2014, by and among Barington Companies Equity Partners, L.P., a Delaware limited partnership, Barington Companies Investors, LLC, as investment advisor to certain investment accounts, Ancora Advisors, LLC, James A. Mitarotonda, Joseph R. Wright, Jr., George W. Hebard III and Ebix, Inc. (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated March 31, 2015).
31.1*		Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) (Section 302 of the Sarbanes-Oxley Act of 2002).
31.2*		Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) (Section 302 of the Sarbanes-Oxley Act of 2002).
32.1*		Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*		Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101**		XBRL (Extensible Business Reporting Language) - The following materials from Ebix, Inc.'s Quarterly Report on Form 10-Q for the quarter ended March 31, ~~2015,~~2016, formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statement of Stockholders' Equity and Comprehensive Income, (iv) the Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements which were tagged as blocks of text.



* Filed herewith
**Exhibit 101 to this Quarterly Report on Form 10-Q is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934.

3839



PART I — FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

Condensed Consolidated Statements of Income for the three months ended March 31, ~~2015~~2016 and ~~2014~~2015 (unaudited)	2

Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, ~~2015~~2016 and ~~2014~~2015 (unaudited)	3

Condensed Consolidated Balance Sheets at March 31, ~~2015~~2016 (unaudited) and December 31, ~~2014~~2015	4

Condensed Consolidated Statement of Stockholders’ Equity for the three months ended March 31, ~~2015~~2016 (unaudited)	6

Condensed Consolidated Statements of Cash Flows for the three months ended March 31, ~~2015~~2016 and ~~2014~~2015 (unaudited)	7

Notes to Condensed Consolidated Financial Statements (unaudited)	98

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	2425

Item 3. Quantitative and Qualitative Disclosures About Market Risk	3334

Item 4. Controls and Procedures	3435

PART II — OTHER INFORMATION

Item 1. Legal Proceedings	3435

Item 1A. Risk Factors	3435

Item 2. Repurchases of Equity Securities	3637

Item 3. Defaults upon Senior Securities	3637

Item 4. Mine Safety Disclosures	3637

Item 5. Other Information	3637

Item 6. Exhibits	3637

SIGNATURES	3738

EXHIBIT INDEX	3839

Exhibit 31.1
Exhibit 31.2
Exhibit 32.1
Exhibit 32.2
Exhibit 101


	March 31, 2015			December 31, 2014			March 31, 2016			December 31, 2015
	(In thousands)						(In thousands)
Finite-lived intangible assets:
Customer relationships	$	65,992		$	66,783		$	76,373		$	76,275
Developed technology	15,476			15,664			15,129			15,121
Trademarks	2,733			2,751			2,722			2,729
Non-compete agreements	755			751			764			743
Backlog	140			140			140			140
Database	212			212			212			212
Total intangibles	85,308			86,301			95,340			95,220
Accumulated amortization	(38,433		)	(36,930		)	(45,199		)	(43,372		)
Finite-lived intangibles, net	$	46,875		$	49,371		$	50,141		$	51,848

Indefinite-lived intangibles:
Customer/territorial relationships	$	30,887		$	30,887		$	30,887		$	30,887


	United States		Canada		Latin America		Australia		Singapore		New Zealand		India		Europe		Total		United States		Canada		Latin America		Australia		Singapore		New Zealand		India		Europe		Total
External Revenues	$	48,537	$	685	$	1,496	$	8,678	$	1,047	$	578	$	989	$	1,743	$	63,753	$	52,796	$	847	$	1,137	$	7,792	$	1,434	$	391	$	2,026	$	4,643	$	71,066
Long-lived assets	$	384,092	$	7,164	$	7,708	$	524	$	68,493	$	319	$	37,426	$	24,507	$	530,233	$	372,004	$	6,968	$	6,708	$	171	$	68,718	$	221	$	76,789	$	26,567	$	558,146


	United States		Canada		Latin America		Australia		Singapore		New Zealand		India		Europe		Total		United States		Canada		Latin America		Australia		Singapore		New Zealand		India		Europe		Total
External Revenues	$	34,800	$	1,437	$	1,482	$	9,729	$	1,144	$	650	$	110	$	2,052	$	51,404	$	48,537	$	685	$	1,496	$	8,678	$	1,047	$	578	$	989	$	1,743	$	63,753
Long-lived assets	$	304,070	$	8,442	$	11,282	$	785	$	68,693	$	99	$	24,795	$	28,381	$	446,547	$	384,092	$	7,164	$	7,708	$	524	$	68,493	$	319	$	37,426	$	24,507	$	530,233


	Three Months Ended March 31, 2015				Three Months Ended March 31, 2014				Three Months Ended March 31, 2016				Three Months Ended March 31, 2015
	As Reported		Pro Forma		As Reported		Pro Forma		As Reported		Pro Forma		As Reported		Pro Forma
	(unaudited)				(unaudited)				(unaudited)				(unaudited)
	(In thousands, except per share data)								(In thousands, except per share data)
Revenue	$	63,753	$	64,003	$	51,404	$	65,336	$	71,066	$	71,066	$	63,753	$	66,531
Net Income	$	18,336	$	18,518	$	15,417	$	14,413
Net Income attributable to Ebix, Inc.									$	22,159	$	22,159	$	18,336	$	17,660
Basic EPS	$	0.51	$	0.52	$	0.40	$	0.38	$	0.67	$	0.67	$	0.51	$	0.49
Diluted EPS	$	0.51	$	0.52	$	0.40	$	0.37	$	0.67	$	0.67	$	0.51	$	0.49

(in thousands)

Fair Value at March 31, ~~2015~~2016

Valuation Technique

Significant Unobservable
Input

Contingent acquisition consideration:
(Qatarlyst, ~~HealthCare Magic, Vertex,~~PB Systems, and i3Via Media acquisitions)

$~~5,330~~3,742

Discounted cash flow

Projected revenue and probability of achievement